IE44707B1 - Proline derivatives and related compounds - Google Patents

Proline derivatives and related compounds

Info

Publication number
IE44707B1
IE44707B1 IE305/77A IE30577A IE44707B1 IE 44707 B1 IE44707 B1 IE 44707B1 IE 305/77 A IE305/77 A IE 305/77A IE 30577 A IE30577 A IE 30577A IE 44707 B1 IE44707 B1 IE 44707B1
Authority
IE
Ireland
Prior art keywords
compound
proline
hydrogen
acid
hydroxy
Prior art date
Application number
IE305/77A
Other versions
IE44707L (en
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/657,792 external-priority patent/US4046889A/en
Priority claimed from US05/751,851 external-priority patent/US4105776A/en
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of IE44707L publication Critical patent/IE44707L/en
Publication of IE44707B1 publication Critical patent/IE44707B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
    • C07C53/19—Acids containing three or more carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The compounds of formula I are prepared by N-acylation of a compound of formula II' by means of an acid of formula III'. In these formulae, R is a hydroxyl, NH2 or alkoxy group, R1 and R4 are each H or an alkyl, phenyl or phenylalkyl group, R2 is H or an organic substituent, R3 is H or a hydroxyl or alkyl group, m is 1, 2 or 3 and n is 0, 1 or 2. The acid of formula III' can be replaced by a functional derivative of the latter or, when n is 1, by an acrylic acid of formula R4CH=C(R1)-COOH. In the latter case, after the acylation, a thiol or thioacid R2SH is added to the double bond of the acryloyl residue. The compounds of formula I are therapeutically active in the treatment of blood hypertension (high blood pressure).

Description

This invention provides new proline derivatives and related compounds which have the general formula (I) H2? (CH).
R2- S~ W SHCO gH-COR wherein R is hydroxy, NH^ ox lower alkoxy; R^ and R^ each is hydrogen, lower alkyl, phenyl or phenyl-lower alkyl; R2 is hydrogen, lower alkyl, phenyl, substituted phenyl wherein the phenyl substituent is halo, lower alkyl or . lower alkoxy, phenyl-lower alkyl, diphenyl-lower alkyl, triphenyl-lower alkyl, lower alkylthiomethyl, phenyllower alkylthiomethyl, lower alkan^fli? ll II amidomethyl, Rg-C-, Rg-M-C-,Rg-NH-C-,Rg-S- or f, ,, Rg is hydrogen,hydroxy or lower alkyl; Rg is lower alkyl, phenyl or phenyl-lower - 2 4 «1 7 Ο 7 air;·) ,-. ’'or; alkyl, phenyl, substituted olo:y-i, .·/. toi ·-..'·.. substituent is nolo, 1-:::/: :1/-/ - I/::: alkoxy), oy aypoy-k. /.::: alkyl :: amino'-carboxy jaC’-asr ::/::1 ‘l k *4 > I , .·..- .i~ic~ty:~ — cc — ca-iari- s>oi ; a -v Π n y ·.· J /-a- - · er .: // : .- -/ 0 oo 2, ://-:.: a ' -on. as ;oogaa.ala witi. .bases and processes for making them Tie /////:/ ://:·/,/: 5.-/1/-:/:::/ carbon atoms.
Sack ok 11: ://:/:.: 1/::.:1:./ ?. orbsaitrant 1:, , r and R. 2. O *» is as;.,//-/:1: when k.aa rybstituer.-c is other than hydrogen.
Tea ?ayeaiacn in its bread aspects includes proline and relate-:; ••'.arivatives keying formula I above. Within this broad grout, because of their properties, certain subgroups are p/e::'::/: c-cer others. ::::11-: preferred are those compounds of formula I wherein R it hydroxy or lower alkoxy; is hydrogen cr i-trar alkyl; :/ 1: · --.1-.0- ·.; R_~C'j, Kg-S·-. or R?; R-, and H,j '///. :S /:://:/1: yc i- l-'rs?: alkyl; especially methyl or phenyl: in loner alkyl, especially methyl or ethyl; si :: I, n lo 0, 1 or ?, :::/::/// i; anl P. wherein R, R1 , Ά- , ? . , κ and n h/·: the rare preferences as above and p is 0. 4470·? Especially preferred are those compounds which have the formula (II) · Ro— S — (CH-) — CH— CO - K 2 2 n COR wherein R is hydroxy or lower alkoxy; ' R^ is hydrogen or lower alkyl; r is hydrogen, R -CO-, R -S- or R ; 6 7 Rg is lower alkyl or phenyl, especially the first; R is lower alkyl; o and n is 0, 1 or 2.
Within the group of compounds represented by formula II, the following are still more preferred subgroups in the order (a to r ) of increasing preference to the compounds which are especially preferred embodiments: a) R is hydroxy b) n is 1 c) r2 is hydrogen or lower alkanoyl d) r2 is hydrogen e) r2 is acetyl 20 f) R^ is hydrogen or lower alkyl g) r^ is hydrogen or methyl h) R is hydroxy, Rx is hydrogen or methyl i) R is hydroxy, R^ is hydrogen or methyl, 1?2 is or acetyl and n is 0, 1 or 2 25 j) R is hydroxy, R^ and K2 each is hydrogen and n is 0 - 4 Κ; Η :.3 nyc-cry, :.s hydrogen, is acetyl and n is i. ·-' *· - b i-ydrcxy, is methyl, ? j.g acetyl and n is 1 vyO-i.., - and fl ·..·-. is hydrogen and *i is i ii. .: :.= hydroxy, is methyl, p i3 hydrogen and .- is 1 is hyirouy, is hydrcren, is lower ilky2 rhio a is 1 ?> 1., is M > R . , fi P.-IC —— y _oc — Cii - fCii ) .: a tach i is hydroxy; Id is hydrogen or lower allyl. especially hydrogen or methyl? and n is 0 co 2, especially 1. c, r„ is wherein H is O or s i'i ri is nc-;-!H-c- wherein M is 0 or 5, preferably s.
Xt.’wrll bs appreciated that combinations of the iorsgcing, where applicable, are among the preferred groups.
Tne stereoisomers in which the proline is in the h-form are especially preferred. i.; 1::.-.--0 nlnyj. groups represented by tiny oi tno variables are straight ar.d oranchod cnarn hydrocarbon radicals from r-cn'/l ro neptyl, tor example, metiiy.,, ethyl, propyl, isopropyl, octyl, isobutyl, t-butyl, pentyl and ;-:y groats are cf tne came kind havin en, tor example, -.thoxy, ethoxy, .I·.;..:'.. ,· end t-hutexy.
Cj and C., members, of both isopantyl. The lower aiho. 1 to 7 carbons linked to oryg propoxy, tsoprrycc,/, butoxy, The ί.,-·/Λ merotrs, especially X 'i 44·7θ7 types are preferred. Phenylmethyl is the preferred phenyllower alkyl group.
The lower alkanoyl groups are those having the acyl radicals of the lower (C^-C/ fatty acids, for example, acetyl, propionyl, butyryl and isobutyryl.- Similarly those lower alkanoyl groups having up to four carbons, and especially acetyl, are preferred.
The term halo means the four common halogens but chlorine and bromine are preferred. The substituted phenyl groups preferably bear the substituent in the 4-position of the ring. The hydroxy-lower alkyl groups i have a hydroxy group on an alkyl chain such as those described above, preferably on the terminal carbon, e.g., hydroxymethyl and 2-hydroxyethyl. The amino(carboxy)lower alkyl groups have one amino and one carboxy on a lower alkyl group such as those described above,. preferably both on one carbon, e.g., on the terminal carbon as in the preferred 2-amino-2carboxyethyl group.
The products of formula I and the preferred subgroups can be produced by various methods of synthesis.
In general, the products of this invention are of the formula produced by acylating a compound (III) (CH).
H2C’ HN- CH—COR with an acid of the formula (IV) R.
I4 (CH), CH — COOH - 6 or its cirst-i :,-- , ,0.,,O, the fine? product can be produced not only by direct acylation with an acid ,ί formula 17 but also by iotarc.ediates such as (sj ω-halo-lkanoOo acids of the formula ‘i . OH -- COOH :: wherein X is bremo, ,O.c,;· or iodo, or ifc) a tosyloxyalkanoic acid, i.e., b in formula 7 is tosyioxy (CH, Oi a substituted acrylic icL'.l of she formula CH—C-COOh The product o: this acylr.tiO’i is then subjected tc displacement or addition with the anion cf a thiol or thioacid of the formula {vii ; Iw-SH Acylation can also be effected with a thiolactone of ths formula S wherein n is 1 or 2, or a .torc-jpcoaikancio acid of the formula ilzj '4 . wherein Y is Rg or, in addition, if a product of formula I wherein Rg is hydrogen is desired, then Y can also be a protecting group such as (a) RCHgO-^^_CHg--, (b) a· (c) CH^COMHCH, (d) R-O-C-CH-(CH) -S- or other sulfur protecting group. Dsprotection can be effected by . Conventional means such as treatment with hot trifluoroacetic acid, cold trifluoromethanesulfonic acid, mercuric acetate, sodium in liquid ammonia or 2inc and hydrochloric acid. For a review of these methods see Methoden der 1° organischen Chemie (Houben-Weyl), Vol. XV, part I, page 736 et seq. (1974).
When the acid of formula IV is used as the acylating agent, the acylation can be effected in the presence of a coupling agent such as dicyclohexylcarbodiimide, T5 or the acid can be activated by formation of e.g. its mixed anhydride, symmetrical anhydride, acid chloride, acid ester or use of Woodward reagent K, N-ethoxycarbonyl-2ethoxy-1,2-dihydroquinoline. a For a review of the methods for acylation, see Methoden der Organischen Chemie .20 (Houben-Weyl), vol. XV, part II, page 1 et seq. (1974).
Compounds of formula III include, for example, proline, hydrbxyproline, 4-methylproline, pipecolic acid, -hydroxypipecolic acid, azetidine-2-carboxylic acid and their lower alkyl esters. The acylation of such compounds is described in greater detail below.
According to a preferred method for producing compounds of formula I, especially wherein Rg is Rg-CO-, an acid or ester of formula III is coupled with a haloalkanoic acid of the formula - 8'έ ? β ί cp : — ch - cooh I; vliiSrsik λ : s λ bcictsh.- pref-trabiy -./•k'.ari.j- or bromine. This ,/: .jS- ://: ,::.5 5,/ cf res ’:', -..-..-....::0 in which tha said IV is activated.· prior to rsaction with t -. acid III, involving formation or .--g. ε mirs-' anhydride,- syncs fcr real anhydride, acid shier'.it; a-.tins ssfcsr, or use of He .-.Sward reagent K, EEOC· C.i—afcifczr efctbratacr:7--r, 2 - dihy rc;nqciroline)., this reaction is a compound' of the (CH5--------CHI: The rrcluct or itrsaii b ie subjected to a displacement 37=action with the anion of a thicacid of ths formula (VII) h„-Sh yielding a product of the formula Cilj P H.C— (CUi 11 ] ΪΛ R.z ..rfcfci R. is ths pref-ci (bi'li fCHi —-Ctl - CC — H ~ Co-COR n ::,: crodtcc can then be converted to P — - CH-COH P !ciU. by ammonolysis. When R2 is a protecting group, then the compound of formula XII can be obtained bydeprotection as described above. When R is an ester group (i.e., R is lower alkoxy), the ester group can be removed, e.g., when R is tert, butoxy or tert, amyloxy, by treatment of the ester of formula XI or XII with trifluoroacetic acid and anisole to give the corresponding free acid. When other alkoxy groups are present, alkaline hydrolysis will yield the corresponding acid.
A variation of this procedure involves the use of an acrylic acid of the formula (VI> Rr I4 i1 CH=C-COOH as starting material. This acrylic acid is first converted to the acid halide form then made to react with a compound of formula III to obtain a compound of the formula (XIII) *3 R. R. H.C- (CH) I I I | m CH=C— CO—N -CH-COR and this intermediate is subjected to the addition reaction with the thiol or thioacid VII as described above.
A tosyloxyalkanoic acid of the formula (XIV) R. R! I4 I1ch3~ so2°-(ch)— CH-COOH can also be used as the agent to acylate the acid of formula III, then the acylation product is subjected to the displacement reaction, as described above.
The acrylic acid of formula VI can alternatively be first made to react with the thioacid 'of formula VII to - 10 ,i 4 7 Ο 7 , obtain t protect of d:e formula (Λ/1 ? r it. — v—Ch—CH— -ittt'i wiilfib is et over-.so w itv ttii halide, e.g., with thionyl chloric2, then coupled to ths compound of formula III and ‘5 tne s.vk seqtttos ts ass -a then followed. its 3-sid or tstar of formula III can also bs acylated with a ’jivtestii fora cf a o-mereaptoaika-coic acid of the formula (λVI) 7- A, i 'J i ?.0-s- :c;-n ,.-ch-cgoh ί ' rhsiiiu ή, is ths “protectinggroup. Such protecting groups car. take the form desosi bed above.
Following the acylation, the product can be “deprotected by one of ohe knt;?>i .-.-.echoes referred co above.
Still another acylating agent can take the form of a if thiolaefcone, e.g., s--p?.Opiothiolactor.e or -x-methyl-p-propiothiolactor.e -.
Additional cetaila of preferred modes of producing compounds cf this invention can be found in the following and in the specific examples, io According to a particularly preferred modification, the acid cr ester of formula III is acylated with a haloaikanoyl haiids of the formula ( .V ! II? I? p ? Γ X- (CH) — CH--COX n •ii.ere:a oicr· ii is i:,iipendei.tiy a halogen, preferably chlorine f or b.... m. γ· . is ?..·ν lower ainyi r pheriy 1 -lower alkyl ¢47°7 and n is Ο, 1 or 2. This reaction is effected in an alkaline medium, e.y., dilute alkali metal hydroxide solution, alkali metal bicarbonate or alkali metal carbonate solution at a reduced temperature, e.g., 0° to 15°C. The reaction product is subjected to displacement with the anion of the thiol or thio acid of the formula VII above, also in alkaline medium, preferably alkali metal carbonate solution, and then worked up in conventional manner. The product of this reaction, wherein Rg of formula I is Rr-CO, is converted to the product wherein Rg is hydrogen by ammonolysis, e.g., alcoholic ammonia or concentrated ammonium hydroxide solution, or alkaline hydrolysis, e.g., with aqueous metal hydroxide.
When an acid of formula III is used as starting material, the final product obtained as the free carboxylic acid can then be converted to its ester, for example by esterification with a diazoalkane , e.g. diazomethane, or a l-alkyl-3-p-tolyl-triazene, e.g. l-n-butyl-3-p-tolyltriazene. Treatment of an ester, preferably the methyl ester, v/ith an alcoholic ammonia solution, converts the free acid to the amide, i.e., R is NHg.
According to another variation, an ester, preferably the t-butyl ester, of formula III, in an anhydrous medium such as dichloromethane, tetrahydrofuran or dioxane, is treated with a thioalkanoic acid of the formula (XVIII) ?5 R-S-(CH_)- CH—COOH 2 n in the presence of dicyclohexylcarbodiimide, Ν,Ν'-carbonylbisimidazole, ethoxyacetylene, diphenylphosphoryl azide or similar coupling agents at a temperature in the range of 0 to 10°C. The ester group (I?) can then be removed, for - 12 4 4 7 ο 7 example, fcy treatment with trifluoroacetic acid and anisole at abort rcoo fstyorature. then an ester cf formula III (e.g., r is lower alkoxy, especially- t-butoxy) is acylated rich a thiolactone, e,g.; C-prcpiothiolaztona, cr o-methyi·* 3-prooiothiolactone the zeacician be affected in an anhydrous solvent such as tetrahydrcfuren, dioxane or methylene chloride from at ?t' f to t oom tcmperstore. The c-ster group can be removed with anisole and trrflucroacetic acid as described above.
M II In similar manner, when R is R^-M-C-,'products of form-tin i having this substituent are formed by reacting a compound of formula XII with the halogenated compound P.•-i'l-C-X Σ» or alternatively reacting a compound of formula X with an alkali metal salt or alkaline earth metal salt of the formula (XX) y5 R^-M-C-S-Me wherein Me represents the alkali metal or alkaline earth metal. il When R-, is R products of formula X having this substituent are produced by reacting a compound of formula XII with the appropriately substituted isocyanate or isothiocyanate of ths formula (XXI) Alternatively., ths same products can be produced by coupling an acid of ths formula (XXII) ’ Rc-NH-C-S-(CH)- CH-COOH □ n with an amino acid of formula III.
Compounds of formula I, wherein Rg is lower alkyl, phenyl, 5 . substituted phenyl, phenyl-lower alkyl, triphenyl-lower alkyl, lower alkylthiomethyl or phenyl-lower alkylthiomethyl are produced by reacting a compound of formula XII v/ith the corresponding halide RgX or by reacting a compound of formula X with the corresponding thiol RgSR ·*·η same manner as described above.
When Rg is lower alkanoylamidomethyl, the product of formula I is produced by condensing a compound of formula XII with the corresponding hydroxymethyl-lower alkanoylamide of the formula (XXIII) lower alkyl-CO-NHCHgOH in the presence of an acid catalyst like trifluoroacetic acid.
Products of formula I wherein R. is R.-S can be 2 6 prepared by any of the known methods for the synthesis of mixed disulfides, e.g., by the reaction of a compound of formula(Xll)with a thiosulfinate(χχΐν), thiosulfonate (XXV), sulfenyl halide (XXVI), thiosulfate (XXVII) or sulfenyl thiocyanate (XXVIII) θ i? H (XXIV) R,-S-S-Rc , (XXV) R,-S-S-Rc , (XXVI) R,S-X, fab 0 |, 0 0 (XXVII) Rg-S-SOgH, (XXVIII) - in the particular case R-S-SCN wherein R is f3 CH - (CH) in -S(O)- (CH) CH CO N CH-COR, ρ n - 14 S, F.?, K„ and R, is .·. the same as the corresponding substituents in formula I ?.rd g is 0, chs symmetrical disulfides can be obtained by direct tzidafcior. of a compound of formula XII with iodine. Shen p is 1 or 2, such products are obtained by thr cteiswite oxidation of ths corresponding compound wherein p is 0. Mixed disulfides are obtained by the modification shown in tha examples. iroducts of formula I have or.e or more asymmetric carbons. When P.,, 5b or S(, is other than hydrogen the carbon to which Ih it <3 attached is arysmetrio. These carbon atoms are indicated by an asterisk in formula ϊ. The compounds accordingly exist ia stereoisomeric forms or in racemic mixtures thereof. Ail of these are within the scope of the invention. The above described synthesis can utilize •1? the racemate or one of the enantiomers as starting material.
When the racemic starting material is used in the synthetic procedure, the stereoisomers obtained in the product can be separated by conventional chromatographic or fractional crystallization methods. In general, the L-isomer with 22, respect to the carbon of tiie amino acid constitutes the preferred isomeric form. Also the D-isomer with respect to the α-carbon in tne acyl side chain (i.e., the carbon bearing R ) is preferred.
The compounds of this invention form salts with various inorganic and organic bases which are also within the scope of the invention. Such salts include ammonium salts, alkali netal salts such as sodium and potassium salts (which are preferred}. alkaline earth metal salts such as the calcium end rcatnaeium salts, salts with organic bases, e.g., dicycloiiexylamine salt, benzathine, N-methyl-D-glucamine, hydrabamine salts, salts v/ith amino acids e.g. arginine and lysine. The non-toxic, physiologically acceptable salts are preferred, although other salts may also be used, e.g., in isolating or purifying the product, as illustrated ; in the examples in the case of the dicyclohexylamine salt.
The salts are formed in conventional manner by reacting the free acid form of the product v/ith one or more equivalents of the appropriate base providing the desired cation in a solvent or medium in v/hich the salt is insoluble, cr in water and removing the water by freeze drying. By neutralizing the salt with an insoluble acid such as a cation exchange resin in the hydrogen form (e.g., polystyrene sulfonic acid resin such as Dowex (Trade Mark) 50)or v/ith an aqueous acid and extraction with an organic solvent, e.g., ethyl acetate or ]5 dichloromethane,the free acid form can be obtained, and, if desired, another salt formed. .14 70 7 Additional experimental details arc found in the examples winch are preferred embodiments and also serve as models for the preparation of other «sspcanis.
The compounds cf this invention inhibit the conversion 5 of the decapeptide angiotensin I to angiotensin II and may therefore he used ir. reducing or relieving angiotensin related hypertension. Tne action of the enzyme renin on angiotensinogen, a pseudogiobullr. in blood plasma, produces angiotensin I. Angiotensin ΐ is converted by angiotensin converting enzyme (ACE) to angiotensin II*. The latter is an active pressor substance which l.aa been implicated as the causative agent in various forms of hypertension in various mammalian species, e.g., rats and dogs. The compounds of this invention intervene in the angiotensin (rer.in)->-?ngiotensin I •►angiotensin II sequence by inhibiting angiotensin converting enzyme and reducing or eliminating the formation of the pressor substance angiotensin II. Thus by the administration of a composition containing one or a combination of compounds of formula I or physiologically acceptable salt thereof, angiotensin 2ΰ dependent hypertension in the species of mammal suffering therefrom is alleviated. Λ single dose, or preferably two to four divided daily doses, provided on a basis of 0.1 to 100 mg. per kilogram bodyweight per day, preferably 1 to 50 mg. per kilogram bodyweight per day is appropriate to reduce blood pressure as indicated in the animal model experiments described by S.h. Engel, T- d. Schaeffer, H.H. Waugh and B. Rubin, Free. Soc. Exp. siol. Med. 143, <‘23 (1973). The substance is preferably administered orally, but parenteral routes such as subcutaneous» intramuscular, intravenous or y 44707 . intraperitoneal can also be employed.
The compounds of this invention can be utilized to achieve the reduction of blood pressure by formulating in compositions such as tablets, capsules or elixirs for oral . administration or in sterile solutions or suspensions for parenteral administration. 10 to 500 mg. of a * compound or mixture of compounds of formula I or physiologically acceptable salt may be compounded with a physiologically acceptable vehicle, carrier, excipient, binder, preservative, W stabilizer or flavour, in a unit dosage form as called for by accepted pharmaceutical practice. The amount of active substance in these compositions or preparations should be such that a suitable dosage in the range indicated is obtained.
Illustrative of the adjuvants which may be incorporated in such preparations as tablets and capsules are the following: a binder such as gum tragacanth, acacia, corn starch or gelatin? an excipient such as dicalcium phosphate; a disintegrating agent such as corn starch, potato starch or alginic acid a lubricant such as magnesium stearate; a sweetening agent such as sucrose, lactose or saccharin; a flavoring agent such as peppermint, oil of Wintergreen or cherry. When the dosage unit form is a capsule, it may contain in addition to materials of the above type a liquid carrier such as a fatty oil. Various other materials may be present as coatings or to otherwise modify the physical form of the dosage unit. For instance, tablets may be coated with shellac, sugar or both. A syrup or elixir may contain the active compound, sucrose as a sweetening, agent, methyl and propyl parabens as preservatives, a dye and a flavoring such as cherry or orange flavor.
' Sterile compositions for injection can be formulated - 18 44707 aesoi’uiug to conventic.r.ui mcnmcrdiccl practice by dissolving or sucpendinp tr.s active substance In a vehicle such as wat..-r for injection., a naturally occurring vefutaale oil such -: sisainc oil, oocojurt oil, pe unit oil or cot-ton:.eel oil, cr a synthetic fatty 'chicle such ac eocyl oleate. Buffers, precervativ us end autioniisnia cun Ic insotyerated ay roci'i-eii.
Thue :·'·'···:.':· „0 0313 of its aspecLs U \ invent U·;. prny.i a .: ay ecu Lie; 1 e .’.a ?i:.jtion COtr.rising COlisniluiO of t...- invention ana a unanaoeuiically acceptable vehicle therefur. ua.acdirv to aneuuer . y :.y it p'cviueo a nethc-.i for reinciny blood puuc-ure in cor-hua&a naKmals •.vhich comprises adniulyaouiny a composition comprising a coapound of the invention ar.I a yha. rauaceutically acceptable vehicle therefor.
The follov/inj Examples ? to lp, 15 to 24, 28 to yf 15 58 to 7, 47,48,50 to Ci,of to 141, :45 to 143, 150 to 152, 154 to 155, f't tc 'ιοί. 162 to 7--, 165 to 168 J71 to 175 to 182 are illustrative cf the invention and constitute especially preferred e:;ilcdi:.i.ju·;·.,,; Examples 14, 8h io 17, 37, 16,49, 62, 112,119,155,15:,1 fl,165,169,17' and 172 describe the preface tier. -θ of starting mat iritis. All temperatures are in degrees celsius. 4 7 0 7 . Example 1 1-(2-Benzoylthioacetyl)-L-Proline L-Proline (5,75 g.) is dissolved in N sodium hydroxide (50 ml.) and the solution is chilled in an ice-water bath.
Sodium hydroxide 2N (26 ml.) and chloroacetyl chloride (5.65 g.) are added and the mixture is stirred vigorously at room temperature for three hours. A suspension of thiobenzoic acid (7.5 g.) and potassium carbonate (4.3 g. ) in water (50 ml., is added. After 18 hours stirring at room temperature, the reaction mixture is acidified and extracted with ethyl acetate.
The ethyl acetate layer is washed with water, dried over magnesium sulfate and concentrated to dryness in vacuo. The residue (14.6·g.) is dissolved in ethyl acetate (150 ml.) and dicyclohexylamine (11 ml.) is added. The crystals are filtered •’θ and recrystallized from ethyl acetate, yield 5.7 g. m.p. 151-152°. To convert the salt to the acid, the crystals are dissolved in a mixture of 5% aqueous potassium bisulfate (100 ml.) and ethyl acetate (300 ml.). The organic phase is washed once with water, dried over magnesium sulfate and concentrated to dryness in vacuo, yield 3.45 g.
Example 2 1-(2-Mercaptoacetyl)-L-Proline 1-(2-Benzoylthioacetyl)-L-proline (3.4 g.) is dissolved in a mixture of water (10.5 ml.) and concentrated ammonia (6.4 ml.) ° After one hour, the reaction mixture is diluted with water and filtered. The filtrate is extracted with ethyl acetate and then acidified with concentrated hydrochloric acid, saturated with sodium chloride and extracted twice with ethyl acetate. The ethyl acetate extracts are washed with saturated *5 sodium chloride and concentrated to dryness, yield 1.5 g. - 20 44707 Ti;e product, 1- (T-ciercaptcacctyi;‘-L-proline is crystdllirei.: from ethyl acetate 'm.p. 133-135°).
Example 3 l-{2-Benzoylthioacetyl)-1-Proline /.ethyl Ester 1- (2-aenzoy2thiaacetyi)“L-proiir.e obtained in Example 1, is dissolved in methanol and an ethereal solution of diazomethane is added until there is a persistent yellow color. After 25 minutes, a few drops of acetic acid are added and the solvent is removei in vacua to obtain 1--(2benzoylthioacetyl)-L-proline methyl ester, *“* 1-(2-Mfei.-captoacety 1 i -E-Prcline Amide The product of Example 3 is dissolved in 10¾ methanolic ammonia and the solution is stored at room temperature in a pressure bottle. When thin layer chromatographic analysis indicates that the two aster functions have been ammonolyzed, the reaction mixture is concentrated to dryness to obtain 1-(2-mercaptoacetyl)-L-proline amide.
Example ΞΙ- (2-Bcnzoylthioacetyl)-L-liydroxyprolir.e By substituting L-hydroxyproline for the L-proline in the procedure of Example 1, 1-(2-benzoylthioacetyl)-Lhydroxyproline is obtained.
Example ί 1-(2-Mercaptoacetyl)-L-Hydroxyproline By treating tne product of Example 5 with ammonia aa in Example 2, 1-(-mercaptoacetyl)-L-hydroxyproline is obtained.
Example 7 1- (2-Ben toy lthio a c e t y i, - b-?.zc t id incy 2-Ca tbo xylic Acid' By substituting L-azetidir.c-2-cnrboxylic acrd for the 4 7 0 7 , L-proline in the procedure of Example 1, 1-(2-benzoylthicacetyl)-L-azetidine-2-carboxylic acid is obtained.
Example 8 l-(2-Mercaptoacetyl)-L“fi2etidine-2-Carboxylic Acid 5 By treating the product of Example 7 with ammonia as in Example 2, 1-(2-mercapfcoacetyl)-L-azetidine-2-carboxylic acid is obtained.
Example 9 1- (2-Benzoylthioacetyl)-L-pipecolic Acid 10 By substituting L-pipecolic acid for the L-proline in fche procedure of Example 1, 1-(2-benzoylthioacetyl)-Lpipecolic acid is obtained.
Example 10 1-(2-Mercaptoacetyl)-L-Pipecolic Acid -)5 By treating the product of Example 9 with ammonia as in Example 2, 1-(2-mercaptoacetyl)-L-pipecolic acid is obtained.
Example 11 1—(2-Benzoylthiopropanoyl)-L-Proline L-Proline (5.75 g. ) is dissolved in aqueous N sodium hydroxide (50 ml.) and the solution is chilled in an ice bath with, stirring. 2N sodium hydroxide (25 ml.) and 2-bromopropionyl chloride (8.57 g.) are added in that order and the mixture is removed from the ice bath and stirred at room temperature for one hour. A mixture of thiobenzoic acid (7.5 g.) and potassium carbonate (4.8 g.) in water (50 ml.) is added and the mixture is stirred overnight at room temperature. After acidification with concentrated hydrochloric acid, the aqueous solution is extracted with ethyl acetate and the organic phase is washed with water, dried and -224 4 7 0 7 . concentrated tc dryness. The residue (14.7 g.) is chromatographed on a column of 44ύ g. of silica gel with a mixture of benzene-acetic acid (7:1}. The fractions containing the desired material are pooled, concentrated co dryness, and tne residue is precipitated twice with ether-hexane and converted to:.a .dicyclohexylamine salt in ether-nexane, yield 9.4 g. m.p., (1:2? 148-156°.The dicyclohexylamine salt is converted back to the acid as in Example 1, yield 5.7 g.
Example 12 ‘i 1- (2-Mercaptopropanoyl) -L-Proline 1-(2-Bensoylthiopropanoyl)-L-proline (5.7 g.) is dissolved in a mixture of water (12 ml.) and concentrated ammonium hydroxide (9 ml.) with stirring. After one hour, the mixture is diluted with water (10 ml.) and filtered, The filtrate is extracted twice with ethyl acetate, concentrated to one-third of the original volume, acidified with concentrated hydrochloric acid and extracted with ethyl acetate. The organic phase is washed with saturated sodium chloride, dried and concentrated to dryness in vacuo. The residue, 1-(2-mercaptopropanoyl)-L-proline, is crystallized from ethyl acetate-hexane, yield 3 σ.,ιιι.ρ. (105j 115-120°.
Example 13 1-(3-Benzoylthiopropanoyl)-L-Proline L-Proiins (5.75 g.) is dissolved in normal sodium hydroxide (50 ml.) and the solution is chilled in an ice bath. 3-2romopropionyl chloride (8.5 g.) and 2tJ sodium hydroxide (27 ml.) are added and the mixture is stirred for 10 minutes in the ice bath and three hours at room temperature, k suspension of thiobenzoic acid ¢7.5 g.) and potassium carbonate (4.5 g.) in water ( 50 mi.) is added and the mixture is stirred for 18 hours at room temperature. After acidification with concentrated hydrochloric acid, the aqueous phase is extracted twice with ethyl acetate. The organic layers are dried over magnesium sulfate and concentrated to dryness in vacuo to obtain 1- (3-benzoylthiopropanoyl)-L-proline, yield 7.1 g., m.p. 101-102° (ethyl acetate-hexane).
Example 14 L-Proline tert.-butyl ester L-Proline (230 g.) is dissolved in a mixture of water (1 1.) and 5 N sodium hydroxide ¢400 ml.). The solution is chilled in an ice bath, and under vigorous stirring, 5 N sodium hydroxide (460 ml.) and benzyloxycarbonyl chloride (340 ml.) are added in five equal aliquots during a half hour period. After one hour stirring at room temperature, the mixture is extracted twice with ether and acidified with concentrated hydrochloric acid. The precipitate is filtered and dried. Yield 442 g. m.p. 78-80°.
The benzyloxycarbonyl-L-proline thus obtained (180 g.) is dissolved in a mixture of dichloromethane (300 ml.), liquid isobutylene (800 ml.) and concentrated sulfuric acid (7.2 ml.). The solution is shaken in a pressure bottle for 72 hours. The pressure is released, the isobutylene is allowed to evaporate and the solution is washed with 5% sodium carbonate, water, dried over magnesium sulfate and concentrated to dryness in vacuo,to obtain benzyloxycarbonyl-L-proline tert.butyl ester, yield 205 g.
Benzyloxycarbonyl-L-proline tert.butyl ester (205 g.) is dissolved in absolute ethanol (1.2 1) and hydrogenated at normal pressure with 10¾ Pd on carbon (10 g.) until only a trace of carbon dioxide is observed in the hydrogen exit gas -24-44707 (24 hours). Ths catalyst is filtered off and the filtrate is concentrated in vacuo at 3C ram. Kg. The residue is distilled in vacuo,, to obtain L-proline cert.butyl ester, b.p., 50-51°. 1mm Example 15 1- Q-AcetylthiopropanoyD-L-Proline tert-butyl Ester Υ-Proline tert-butyl ester (5.13 g.) is dissolved in dichloromethane (40 ml.) and the solution is chilled in an ice-water bath. A solution cf dicyclohexylcarbodiimide (6.18 g.j in dichloromethane (20 mi.) is added followed immediately by 3-acetylthiopropionic acid (4.45 g.i. After 15 minutes stirring in the ice-water bath and 16 hours at room temperature, the precipitate is filtered off and the filtrate is concentrated to dryness in vacuo. The residue is dissolved in ethyl acetate and washed neutral. The organic layer is dried over magnesium sulfate ana concentrated to dryness in vacuo to obtain 9.8 g. of 1-(3-acetylthiopropanoyl)-Lproline tert-butyl ester.
Example 16 1-(3-Acetylthiopropanoyl)-L-Proline 1-(3-Acetylthiopropanoyl)-L-proline-t-butvl ester (4.7 g.) is dissolved in a mixture of anisole (34 ml.) and trifluoroacetic acid (53 mi.) and the mixture is kept at room temperature for one hour, The solvents are removed in vacuo and the residue is precipitated from ether-hexane several times. The residue (3.5 g.) is dissolved in acetonitrile (25 mi.) and dicyclohexylamine (2.8 ml.) is added. The crystalline salt is filtered and recrystallized from isopropanol. Yield 3.8 g.. m.p. 176-177°. The salt is reconverted to i-(3-acetyIthiopropanoyl)-L-proline as in . -.2530 Example 1, yield 1.25 g., m.p. 89-90° (ethyl acetate-hexane). Example 17 1-(3-Mercaptopropanoyl)-L-proline tert-butyl Ester To a solution of L-proline tert-butyl ester (3.42 g.) • 5 in dry tetrahydrofuran (10 ml.) chilled in an ice bath, propiothiolactone (1.76 g.) is added. After 5 minutes storage in the ice bath and three hours at room temperature, the reaction mixture is diluted with ethyl acetate '200 ml.) and washed with 5% potassium bisulfate, and water. The organic layer is dried over magnesium sulfate and concentrated to dryness in vacuo. The residue 1-(3-mercaptopropanoyl)-L-proline tertbutyl ester is crystallized from ether-hexans, yield 3.7 g., m.p. 57-58°. 1 Example 18 1-(3-Mercaptopropanoyl)-L-Proline Procedure A 1-(3-Benzoylthiopropanoyl)-L-proline (4.9 g.) is dissolved in a mixture of water (8 ml.) and concentrated ammonium hydroxide (5.6 ml.) and the solution is stored with stirring under argon for one hour. The reaction mixture is diluted with water, filtered, and the filtrate is extracted with ethyl acetate. The aqueous phase is acidified with concentrated hydrochloric acid, saturated with sodium chloride and extracted with ethyl acetate. The organic layers are washed with saturated sodium chloride, dried over magnesium sulfate, and concentrated to dryness in vacuo. The residue,1-(3-mercaptopropanoyl)-L-proline, is crystallized from ethyl acetate hexane, yield 2.5 g.’, m.p. 68-70°.
Procedure B 1-(3-Acetylthiopropanoyl)-L-proline (0.8 g.) is dissolved -έ64 4707 . in 5.5 N mefchanolic ammonia (5 ml., and the solution kept under argcr. at room temperature. .After 2 hours the solvent is removed in vacuo, fche residue is dissolved in water and applied to an ion exchange column on the cyelelDowex 50 (Analytical grade) land elute-.;; with water. The fractions that give thiol positive reaction are pooled and concentrated to dryness, yield 0.6 g. This product is crystallized from ethyl acetatehexanc as in Procedure A co obtain 1-(3-mercaptopropanoyl)-Lproline, Procedure C 1- (3-l'ercaptopropanoyl)-L-proline t-butyl ester (2.3 g.) is dissolved in a mixture of anisole (20 ml.) and trifluoroacetic acid (45 ml.). After one hour storage at room temperature under argon, the reaction mixture is concentrated to dryness .in vacuo and the residue precipitated from ethyl acetatehexane several times. The residue (1.9 g.) is dissolved in ethyl acetate (30 ml.) and dicyclohexylaroine (1.85 ml.) is added. The crystalline salt is filtered and recrystallized from isopropanol, yield 2 g. m.p. 187-188°.
The salt is converted to the acid as in Example 1, yield 1.3 g. The product is crystallized from ethyl acetate hexane as in Procedure A.
Salts Sodium 1-(3-Mercaptopropanoyl)-L-proline (500 mg.) is dissolved in a mixture of water (2.5 ml.) and M sodium hydroxide (2.5 ml.). The solution is freeze dried to obtain the sodium salt.
Magnesium 1-(3-Xercaptcpropanoyl)-L-proline (500 mg.), magnesium oxide ¢49.5 mg./, and water (10 ml.) are stirred -2744707 with slight heating until complete solution is obtained.
Then the solvent is removed by freeze drying to obtain the magnesium salt.
Calcium 1-(3-Mercaptopropanoyi)-2-proline (500 mg.) is dissolved in a mixture of calcium hydroxide (91 mg.) and water (10 ml.), and the solution is freeze dried to obtain the calcium salt.
Potassium 1-(3-Mercaptopropanoyl)-L-proline(500 mg.) is dissolved in a mixture of potassium bicarbonate (246 mg.) and water (10 ml.) and freeze dried to obtain the potassium salt.
N-Methyl-D-Glucamine 1-(3-Mercaptopropanoyl)-L-proline (500 mg.) and N-methyl-D-glucamine (480 mg.) are dissolved in water (10 ml.) and -freeze dried to obtain the N-methyl-D-glucamine salt.
Example 19 1-(3-Mercaptopropanoyl)-L-Hydroxyproline By substituting L-hydroxyproline for the L-proline in the procedure of Example 11 and then treating the product by Procedure A of Example 18, 1-(3-henzoylthiopropanoyl)-Lhydroxyproline and 1-(3-mercaptopropanoyl)-L-hydroxyproline, respectively, are obtained.
Example 20 1-(3-Mercaptopropanoyl)-L-Azetidine-2-Carboxylic Acid By substituting L-azetidine-2-carboxylie acid tertbutyl ester (prepared by substituting L-azetidine-2carboxylic acid for the proline in Example 14) for the Lproline tert-butyl ester in the procedure of Example 15, -2844707 . treating the product as in Example 16 and the 1-(3-acetylthiopropanoylj-L-axetidine-2-carboxylic acid thus obtained by Procedure B of Example 18, 1-- (3-acetylthiopropanoyl)-Lazetidine-2-carboxylic acid tert-butyl aster and 1-{3-mercapto5 propanoyU-L-azetidine-S-cai-boxylic acid, respectively, are obtained.
Example 21 1-(3-Mercaptopropanoylj-L-Pipecolie Acid By substituting L-pipecolic acid tert-butyl ester (prepared by substituting L-pipeeoiic acid for the L-proline in Example 14) for the L-proline tert-butyl ester in the procedure of Example 15 and treating the product by Procedure C of Example 18, 1-f3-mercaptopropanoyl)-L-pipecolic acid tertbutyl aster and 1-(3-mercaptopropanoyl)-L-pipecolic acid, respectively, are obtained.
Example 22 1-(3-Hercaptopropanoyl)-4-Methyl-L-Proline By substituting 4-methyl-L-proline for L-proline in the procedure of Example 13 and then treating the product by Procedure A of Example 18, 1-(3-bGnzoyithiopropanoyl)4-methyl-L-proline and 1- (3-mercaptopropanoyl)-4-methyl-Lproline, are obtained.
Example 23 1- (3-Mercaptopropanoyl)-5-liydroxy-L-Pipccol,ic Acid By substituting 5-hydroxy-L -pipecolic acid for Lproline in the procedure of Example 13 and then treating the product by the Procedure A of Example 18, 1-(3-ber.zoylthiopropanoyl)-5-hydroxy-L-pipecolic, and 1-(3-inercapfcopropanoyl)-5-hydroxy-L-piptcolic acid are obtained. -2944707 . Example 24 1-(3-Mercaptopropanoyl)-D-Proline By substituting D-proline for L-proline in the procedure of Example 13 and then treating the product by Procedure A of .5 Example 18, 1-(3-benzoylthiopropanoyl)-D-proline and 1-(3mercaptopropenoylJ-D-proline, m.p. 68-70°, are obtained.
Example 25 3-Acetylthio-2-Methylpropanoic Acid A mixture of thioacetic acid (50 g.) and methacrylic 1θ acid (40.7 g.) is heated on the steam bath for one hour and then stored at room temperature for 18 hours. After confirming by nmr spectroscopy that complete reaction of the methacrylic acid has been achieved, the reaction mixture is distilled in vacuo and the desired 3-acetylthio-2-methylpropanoic acid is separated in the fraction with boiling point 128.5 -131° (2.6 mmHg.), yield 64 g.
Example 26 3-Benzoylthio-2-t4ethylpropanoic Acid By substituting thiobenzoic acid for the thioacetic acid in the procedure of Example )25, 3-benzoylthio-2methylpropanoic acid is obtained.
Example 27 3-Phenylacetylthio-2-Methylpropanoic Acid By substituting thiophenylacetic acid for the thioacetic acid in the procedure of Example 25, 3-phenylacetyl thio-2-methylpropanoic acid is obtained.
Example 28 1-(3-Acetylthio-2-nicthylpropanoyl)-L-ProIine tert-butyl Ester L-Proline tert-butyl ester <5.1 y.) is dissolved in zn dichloromethane (40 ml.) and the solution stirred and chilled -501470 in an ice bath. Cicyciohexylcarbcdiimide {6.2 g.) dissolved in dichiorcmethane ¢25 nl.t is added followed immediately by a solution of 3-acetyithio-2-methylpropanoic acid (4.9 g.) in dichloromethane (5 ml.). After 15 minutes stirring in the ice bath and IC hours at room temper a ture, the precipitate is filtered off and the filtrate is concentrated to dryness in vacuo. The residue is dissolved in ethyl acetate and washed neutral. The organic pnase is dried over magnesium sulfate and concentrated to dryness in vacuo. The residue 1-(310 acetylthio-2-msthylpropanoyl)-L-proline tert-butyl ester is purified by column enromefcography (silica gel-chloroform,, yield 7.9 g, Example 29 1-(3-Acptylthio-2-r:cthy Inropanoyl)-L-Proline Procedure Λ Tiie i~ (3-aeetylthio-2-methylprapanoyl)-L-proline tert-butyl ester of Example 28 (7.6 g.) is dissolved in a mixture of anisole (55 ml.) and trifluoroacetic acid (110 ml.). After one hour storage at room temperature the solvent is 2o removed in vacuo and the residue is precipitated several times from ether-hexane. The residue (6.8 g.i is dissolved in acetonitrile (40 ml.) and dicyclohexylamine (4.5 ml,) is added. The crystalline salt is boiled with fresh acetonitrile (100 ml.), chilled to room temperature and filtered, yield 3.8 g., m.p, (155) 187-183°, This material is recrystallized from isopropanal [a]^-67° (C 1.4, EtOH). The crystalline dicyclohexylamine salt is suspended in a mixture of 5¾ aqueous potassium bisulfate and ethyl acetate. The organic phase is washed with water and concentrated to dryr.ess. The residue is crystallized from ethyl acetate-hexane to yield tiie 1-(3-««cetyl· -ol44707 • thio-2-D-methylpropanoyl-L-proline,m.p.83-85°(a)J-162(c,I.7,EtOH) Procedure B 3-AcetyIthio-2-m2thylpropanoic acid (8.1 g.) and thionyl chloride (7 g.) are mixed and the suspension is stirred for 16 hours at -room temperature. The reaction mixture is concentrated to dryness and distilled in vacuo (b.p. 80°).
This 3-acetylthio-2-methylprc-panoic acid chloride (5.4 g.) and 2N sodium hydroxide (15 ml.) are added to a solution of L-proline (3.45 g.) in normal sodium hydroxide (30 ml.) chilled in an ice water bath. After 3 hours stirring at room temperature, the mixture is extracted with ether, the aqueous phase is acidified and extracted with ethyl acetate.
The organic phase is dried over magnesium sulfate and concentrated to dryness to obtain 1-(3-acetylthio-2-DL-methylpropanoyl-L15 proline.
Procedure C Methacryloyl chloride (4.16 g.) is added to a solution of L-proline (3.45 g.) in a mixture of water (100 ml.) and sodium bicarbonate (12 g.) chilled in an ice water bath, with vigorous stirring. When the addition is completed, the mixture is stirred at room temperature for two hours, and then extracted with ether. The aqueous phase is acidified with N hydrochloric acid and extracted with ethyl acetate. The organic phase is concentrated to dryness in vacuo, the residue is mixed with thiolacetic acid (3.5 g.), a few crystals of azobisisobutyronitrile are added and the mixture is heated on the steam bath for two hours. The reaction mixture is dissolved in benzeneacetic acid (75:25), and applied to a column of silica gel.
Elution with the same solvent mixture yields the 1-(3-acetylthio30' 2-DL-methylpropanoyl)-L-proline. -3244707 Example 3ii 1-(3-Bonzoylthio-2-irethyipropanoyl>-L-proline tort-butyI EsLer By substituting 3-benzoylthio-2-methyipropanoic acid for the 3-acetylfchio-2-raechylpropanoic acid in the procedure of Example 28, 1-(3-ber.soylthio-2-methylpropanoyl)-L-proline tert.butyl ester is obtained.
Example 31 1- i 3-Phenylaeety 1thio-2-mathylpropanoyl)-L-Proline ter t-butyl Ester ay substituting 3-phenylacetylthic-2-methylpropanoic acid for the 3-acetylthio-2-methylpropanoic acid in the procedure of Example 28,. I-(3-phenylacetylthio-2-me-chylpropanoyl)L-proiine tert butyl ester is obtained.
Example 32 1-(3-Berizoy1thio-2-methyIpropanoyl)-L-proline By substituting 1-{3-benzoyltr.io-2-methylpropanoyl)L-proline tert-butyl ester for the i-(3-acetylthio)-2methylpropanoyl)-l-proline tert-butyl ester in Procedure A of Example 29, 1-(3-benzoylthio-2-methylpropanoyl)--Lproline is obtained.
Example 33 - (3-Phcny lace t y 1 th io - 2-methy 1 propanoy 1) -L- ρ ro 1 i na By substituting 1-i3-phenylacetylthio-2-methylpropanoyl)L-proline tert-butyl ester for 1-(3-acetyl.thio-2-methyipropanoyl)L-proline tert-butyl ester in Procedure A of Example 29, 1-(3-phenylacetylthio-2-raethylpropanoyl)-L-proline is obtained. Example 34 1-(3-Mercapto-2-o-methylpropanoy1)-L-Proline l-(3-Mercapto-2-nethylpropanoyl)-L-proline is obtained by treating the product of each of Examples 29, 32 and as follows: “ 33 “ The thioester (0.85 g., is dissolved in 5.5 K methanolic ammonia and the solution is kept at room temperature for 2 hours. The solvent is removed in vacuo and the residue is dissolved in water, applied to anion exchange column on the H+ cycle (Dowex 50, analytical grade) and eluted with water. The fractions that give positive thiol reaction are pooled and freeze dried. The residue is crystallized from ethyl acetate-hexane, yield 0.3 g. The 1-(3-mercapto-2-0~ methylpropanoyl-L-proline has m.p. 103-104°, (“Ιβ 131 (C,2,EtOH).
Example 35 1- O-Acetylthio^-methylpropanoyli-L-Proline Methyl Ester 1-(3-Acetylthio-2-methylpropanoyl)-L-proline is reacted with an ethereal solution of diazomethane according to the procedure described in Example 3 to obtain l-(3-acetyIthio-2-methylpropanoyl)-L-proline methyl ester.
Example 36 1-(3-Mercapto-2-methylpropanoyl)-L-Proline amide By substituting 1-(3-acetylthio-2-methylpropancyl)~ L-proline methyl ester in the procedure of Example 4, 1-(3mercapto-2-methylpropanoyl)-L-proline amide is obtained.
Example 37 3Acetylthio-2-Benzylpropanoic Acid By substituting 2-benzylacrylic acid for the methacrylic acid in the procedure of Example 25, 3-acetylthio-2-benzylpropanoic acid is obtained.
Example 38 1-(3-Acetylthio-2-benzylpropanoyl)-L-Prollno tert-butyl Ester By substituting 3-acetylthio-2-benzylpropanoic acid for the 3-acetylthio-2-raethylpropanoic acid in tha procedure of -34 44707 . Example 22, 1-{3-acetylchio-2-benzylpropanoyl)-L-proline tert-butyl estar is obtained.
Example 39 1- (3-Acetylthio-2-benzylpropanoyl) -L-Frolin·; The product of Example 38 is substituted for the 1- (3-acetylthio-2-methyrprcpanoyl-L-proline tert-butyl ester in the Procedure A of Example 29 to obtain 1-{3-acetylthio2- benzylpropanoyl) --l-proline.
Example 40 Id ' 1~O-Mercapto-x-bonsylpropanoyl)-L-Prolino 1-(3-Acetylthio-2-benzylpropanoyi)-L-proline is treated with methanolic ammonia according to the procedure of Example 34 to obtain 1- (3-wercapfo-2-benzylpropanoyl) -Lnroline as ar. oil, R. = 0.47 (silica gel, benzene-acetic acid £ 75:25).
Example 41 1- (3-Mercapto-2-nietliylproparioyi)-L-)iydroxy Proline: By substituting L-hydroxy proline tert-butyl ester tert-butyl ether in the procedure of Example 28, treating the 20 product according to Procedure Λ of Example 29 and then continuing as in Example 34, 1-(3‘-acetylthio“2-methylpropanoyl)L-hydroxyproline tert-butyl ester, tert-butyl ether 1-(3acetylthio-2-methylpropanoyl)-L-hydroxyproline and 1-(3mercapto-2-methyIpropanoyl)-L-hydroxyproline, respectively, -5 are obtained.
Example 42 1- (3-Korcapto-2-metliylpropanoy i) -L-Azetidine-2-Carboxylie Acid fly substituting L-azetidine-2-carboxylic acid tertbutyl ester in tiie procedure of Example 28, treating the product 30 according to i’rocedure A of Example 29 and then continuing as . in Example 34 , 1- (3-acetylthio-2-methylpropanoyl)-L-azetidine2-carboxylic acid tert-butyl ester, 1,3-acefcylthio-2-methylpropanoyl)-L-azetidine-2-carboxyiic acid and I-(3-mercapto2-methylpropanoyl-L-azetidine-2-carboxylic acid are obtained.
Example 43 I- (3-Mercapto-2-methylpropanoyl)-L-Pipecolic .Acid By substituting L-pipecolic acid in the procedure of Example 28, treating the product according to Procedure A of Example 29 and then continuing as in Example 34 , l-(3-acetyl10 thio-2-methylpropanoyl)-L-pipecolic acid tert-butyl ester, 1-(3-acetylthio-2-methylpropanoyl)-L-pipecolic acid and 1-(3mercapto-2-raethylpropanoyl)-L-pipecolic acid, respectively, are obtained.
Example 44 -)5 1- (4-Benzoylthiobutanoyl)-L-Proline To a solution of L-proline [2.88 g.) in normal sodium hydroxide (25 ml.) chilled in an ice bath, 2N sodium hydroxide (12.5 ml.) and 4-chlorobutyryl chloride (3.5 g.) are added.
The reaction mixture is stirred at room temperature for 3.5 hours and a suspension of thiobenzoic acid (3.75 g.) and potassium carbonate (2.4 g.) in water (25 ml.) is added. After overnight stirring at room temperature, the reaction mixture is acidified with concentrated hydrochloric acid and extracted with ethyl acetate. The organic layer is dried over magnesium sulfate and concentrated to dryness in vacuo. The residue is chromatographed on a column of silica gel with benzeneacetic .acid (7:1). The fractions containing the desired material are pooled and concentrated to dryness, yield 1.35 g. A small aliquot of this material is dissolved in ethyl acetate and dicyclohexylamine is added until pH 8-10 (on a wet pH paper). - 36 44707 The dicyclohexylamine salt crystallizes out, immediately, m.p. 159-151°.
E.xairple 45 1- (4-Morcaptooucar.oyl)-L-Prolir.e I-(4-3enzyIthiotucanoyl)-L-proline ¢1.08 y.) is .dissolved in a mixture of water (4 ml.) and concentrated ammonia (2.7 ml.). After one hour stirring at room temperature, the mixture is diluted with water, filtered, extracted with ethyl acetate, and the aqueous phase was concentrated in vacuo. This ammonium salt of 1-(4-mercaptcbutancyl)-L-proline is purified by ion exchange chromatography on a column of diefchylaminoeuhyl-Sephadex(cross linked dextran) with a gradient af ammonium bicarbonate, yield 9.7 g. The ammonium salt is dissolved in water (2 ml.) and applied to a column of Dowex 50 sulfonic acid resin analytical grade in the hydrogen form, ar.d the free acid is eluted with water. The fractions containing the desired material (suifhycryl reagent and carboxyl reagent positive) are pooled and freeze dried to obtain 1-(4-mercaptobutanoylj-L-proline. The dicyclohexyl ammonium salt is produced by the procedure of Example 44, m.p. 157-158°.
Example 4 0 4-Bromo~2-Mctliylbutanoic Acid Ethyl-4-bromo-2-raethy!butanoate {G. Jones and J. Wood, Tetrahedron, 2i, 2951 (1965)] (1.04 g.) is dissolved in dichloromethane (50 mi.) and cooled to -10°. A 1 M solution of boron tribromide in dichloromCtnane (50 ml.) is added dropwise with stirring and the stirring is continued for o o hour at -10 and 2 hours at 25 . - 5? _ The reaction is terminated £4707 by the careful addition of water. The layers are separated and the organic phase is washed with water, dried and concentrated to dryness to obtain 4-bromo-2-methylbutanoic acid.
Example 4 7 1-(4-Benzoylthio-2-methylbutanoyl)-L-Proline a) 4-Bromo-2-methylbutanoic acid (8 g.) and thionyl chloride (7 g.) are mixed and the mixture is stirred for 16 hours at room temperature. The reaction mixture is concentrated to dryness and distilled in vacuo. b) To a solution of L-proline (2.88 g.) in normal sodium hydroxide (25 ml.) chilled in an ice bath, 2N sodium hydroxide (12.5 ml.) and the 4-bromo-2-methylbutanoic acid chloride obtained in part (a) (3-.9 g.) are added. The reaction mixture is stirred at room temperature for 3.5 hours and a suspension of thiobenzoic acid (3.75 g.) and potassium carbonate (2.4 g.) in water (25 ml.) is added. After overnight ‘stirring at room temperature, the reaction mixture is acidified with concentrated hydrochloric acid and extracted with ethyl acetate. The organic layer is dried over magnesium sulfate and concentrated to dryness in vacuo. The residue is chromatographed on a column of silica gel with benzene-acetic acid (7:1). The fractions containing the desired product, 1-(4-benzoylthio-2-methylbutanoyl)-L-proline are pooled and concentrated to dryness in vacuo.
Example 48 1-(4-Mercapto-2-methylbutanoyl)-L-Prolino By substituting 1-(4-benzoylthio-2-methylbutanoyl)L-proline for the 1-(4-benzoylthiobutanoyl)-L-proline in the procedure of Example 45, 1-(4-mercapto-2-methylbutanoyl)L-proline is obtained. -38 44707 * Example 4 9 4-Bromo- .l-benzylbutanolc ac id By substituting ethyl-4~brosr.a-2-benzylbutanoate [prepared by the procedure of G. Jones and J. Wood [Tetrahedron, 21., 2961 (1965) starting with diethylbenzylmaionate J] for the ethyl-4-broric-2-methylbutanoate in the procedure of Example 16, 4-bro.-no-2-ben2ylbufcar.oic acid is obtained.
Example 5¾ 1-(4-benzoylthio-2-bennyloutancyl)-L-Proline W fly substituting 4-bromo-2-benzylbutanoic acid for the 4-bromo-2-methylbutanoic acid in the procedure of Example 47, 1-(4-benzoylthio-2-benzylbutanoyl)-L-proline is obtained.
Example 51 1- (4-Mercapto-2-bonzyibutanoyl)-L-Proline By substituting 1-(4-bencoylthio-2-benzylbutanoyl)-Lproline for the 1-(4-benzoylthiobutanoyl)-L-proline in the procedure of Example 45, 1-(4-mercapto-2-benzylbutanoyl)L-proline is obtained.
Example 52 1-(4-Mercaptpbutanoy1)-L-Hydroxyproline By substituting L-hydroxyproline for the L-proline in the procedure of Example 44 and subjecting the product to ammonolysis as ir. Example 45, 1-(4-benzoylthiobutanoyl)-L-hydroxy25 proline and 1-(i-mercaptobutanoyl)-L-hydroxyproline, respectively, are obtained.
Example 53 1- (4-Hercaptobutanovli-L-Azotidlne-2-Carboxylic Acid By substituting L-azctidine-2-carboxylic acid for tho 30 L-proline in the procedure of Example 44 and subjecting the product to ammonolysis as in Example 45, 1-(4-banzoylthiobutanoyl)-L-azetidine-2-carboxyiic acid and 1-(4-mercaptobutanoyl)-L-azetidine-2-carboxylic acid, respectively, are obtained.
Example 54 1—(4-Mercaptobutanoyl)-L-Pipecolic Acid By substituting L-pipecolic acid for the L-proline in the procedure of Example 44 and subjecting the product to ammonolysis as in Example 45, 1-(4-benzoylthiobutanoyl)-Lpipecolic acid and 1-(4-mercaptobutanoyl)-L-pipecolic acid, respectively, are obtained.
Example 55 1-(3-/Acetylthiobutanoyl)-L-Proline tert-butyl Ester Dicyclohexylcarbodiimide (6.2 g.) and 3-acetylthiobutyric acid (4.86 g.) are added to a solution of L-proline tert-butyl ester (5.1 g.) in dichloromethane (60 ml.) stirred in an ice bath. After 15 minutes the ice bath is removed and the mixture is stirred at room temperature for 16 hours.
The precipitate is filtered, the filtrate is concentrated to dryness and the residue is chromatographed on a column of silica gel with chloroform to obtain 1-(3-acetylthiobutanoyl)L-proline tert-butyl ester, yield 5.2 g.
Example 5G 1-(3-Acetylthiobutanoyl)-L-Proline The 1-(3-acetylthiobutanoyl)-L-proline tert-butyl ester of Example 55 (5.2 g.) is dissolved in a mixture of trifluoroacetic acid (60 ml.) and anisole (30 ml.) and the solution is kept at room temperature for one hour. The solvents are removed in vacuo and the residual 1-(3-acetylthiobutanoyl)-L-proline is reprecipitated from ether-hexane several times, yield -40Ϊ4707 . 4 g.. lie dicyclohexylamine .'salt is made by the procedure of Example 44, m.p. 175-176°.
Example 5? 1- (3-Mercaptobutanoylj -L-Prolinc 5 The 1-(3-acetylthiobutanoyl)-L-proline of Example 56 (0.86 g.) is dissolved in 5.5 N. methanolic ammonia (20 ml.) ar.d the reaction raixture is stored at room temperature for 2 hours. The solvent is removed in vacuo and the residue chromatographed or. an ion exchange column (Dowex 50) with water. The fractions containing the desired i-(3-mercaptobutanoyl)-L-proline are pooled and lyophilized, yield 0.6 g. The dicycioiicxylamin- sale is produced by the o procedure of Example 44, m.p. 183-184 . 1-[3-[[(Ethoxy)carbonyl]thio]propanoyl]-L-proline Ethyl chloroformate (1.2 g.) is added to a solution of 3-mercaptopropanoyl-L-proline [2.03 g.) in normal sodium bicarbonate (30 ml.) and the mixture is stirred vigorously at 5° for one hour, and for two hours at room temperature. After acidification with concentrated hydrochloric acid,· the mixture is extracted with ethyl acetate. The organic phase is washed with water, dried over magnesium sulfate, and concentrated to dryness to yield 1-[3-[[(ethoxy)carbonyl]thiolpropanoyl]L-proline. -41' 44707 , Example 59 1-(3-[[(Ethoxy)thiocarbonyl]thio]propanoyl]-L-proline Aqueous 2N sodium hydroxide (25 ml) and 3-bromopropionyl chloride (8.5 g) are added to a solution of L-proline (5.75 g) in N sodium hydroxide (50 mi) chilled and stirred in an ice bath. After five minutes the ice bath is removed and the stirring is continued at room temperature. After three hours ethyl xantogenic acid potassium salt (9.6 g) is added and the mixture is stirred overnight at room temperature. The solution is acidified with concentrated hydrochloric acid and extracted with ethyl acetate. The organic layer is concentrated to dryness and the residue is chromatographed on a column of silica gel with a mixture of benzene-acetic acid (7;lj as solvent, to yield 1- [3- [ [(ethoxy)thiocarbonyl]thiolpropanoyl]-L-proline, m.p. 94-95°.
Example 60 1-(3-[[{Benzylthio)carbonyl]thio]propanoyl]-L-proline A solution of benzylthiocarbonyl chloride (11 ml) in dioxane (20 ml) is added in five portions to a solution of 1-(3-mercaptopropanoyl)-L-proline (1.6 g) in normal sodium bicarbonate (24 ml) chilled in an ice bath, over a period of 30 minutes. The ice bath is removed and the stirring is continued for 2.5 hours at room temperature. After acidification with concentrated hydrochloric acid, the aqueous phase is extracted with ethyl acetate. The organic phase is dried over magnesium sulfate and concentrated to dryness to yield 1- [3- ([ (banzylthio)carbonyl]thio]propanoyl]-L-proline. -4244707 Example 61 1-[3-f[{Ethylthio)tfeiocarbonyl3 thioIpropanoyl]-L-proline Aqueous 2N sodium hydroxide (25 ml) and 3-bromopropionyl chlorine (8.5 g) are added to a solution of L-proline (5.75 g) in N sodium nydroxide (SC sn) chilled and stirred in an ice bach. After five minutes, tlie ice bath is removed and the stirring is continued at room temperature. After three hours, ethyl trithiocarbonate potassium salt (10.5 gj is added and the mixture is stirred at room temperature overnight. After acidification with concentrated hydrochloric acid, the mixture is extracted with ethyl acetate. The organic layer is dried over .magnesium sulfate and concentrated to dryness to yield 1- [3~ f ί(ethylthijthiocarbonyijthio]prcpunoyl]-L-proline.
Example 62 3-([(Methylamino;thiocarbqnyllthio]propionic acid Methylisothiocyanate (4 g) is added to a solution of 3-mercaptopropior.ic acid (5.3 g) in a mixture of pyridine (250 ml) and 0.5 N sodium hydroxide (100 mi). The solution is kept at 40 for two hours and concentrated to dryness in vacuo. The residue is dissolved in water (100 ml,), acidified with concentrated hydrochloric acid and extracted with ether. The organic phase is concentrated to dryness to yield 3-ί[(methylamino)thiocarbonyl]thio]propionic acid, m.p. 86-87°.
. Example 63 1-[3-[[(Methylamino)thiocarbonyl]thio]propanoyl[-L-prollne tert-butyl ester To a solution of L-proline tert-butyl ester (1.71 g' and 5 hydroxybenzotriazole (1.35 g) in dichloromethane (10 ml) chilled and stirred in an ice bath, dicyclohexylcarbodiimide (2.06 g) and 3-methylaminothiocarbonylthiopropionic acid (1.79 g) are added. After 15 minutes, the bath is removed and the stirring is continued overnight. The precipitate is filtered off and the filtrate is diluted with ethyl acetate and washed neutral. The organic phase is concentrated to dryness to yield 1- [3- [ [ (methylamino)thiocarbonyl]thio]propanoyl]-L-proline tert-butyl ester, m.p. 129-130°.
Example 64 1-(3-(( (Methylamino)thiocarbonyl]thio]propanoyl]-L-proline A) 1-(Methylaminothiocarbonylthiopropanoyl)-L-proline tertbutyl ester (0.98 g) is dissolved in a mixture of anisole (3.6 ml) and trifluoroacetic acid (7.5 ml). After one hour at room temperature the mixture is concentrated to dryness in vacuo and 2θ ' the residue precipitated from ether-hexane three times. This material is chromatographed on a column of silica gel with a solvent mixture of benzene-acetic acid (75:25) to yield 1-(3[[(methylamino)thiocarbonyl]thio]propanoyl]-L-proline, = 0.4 [silica gel-benzene:acetic acid (75:25)]. The o dicyclohexylammonium salt has m.p. 127-129 . -44-4 4 7ό~7 . Β) Methyiisothiocyanate (4 y) is added to a solution of 3mercaptopropanoyl-L-prolir.e (10.1 g) in a mixture of pyridine (250 ml) and 0.5 N sodium hydroxide (100 mi!. The solution is kept at 40° for two hours and concentrated to dryness in vacuo.
The residue is dissolved in water (100 ml), acidified with concentrated hydrochloric acid and extracted with ethyl acetate.
The organic phase is concentrated to dryness to yield 1-[2~[ I (methylamiao)tkioearbonyl]thio]propanoyl]-L-proline.
Example 65 1-(3-(((Ethylaraino)carbonyllthio]propanoyl]-L-proline Etnylisocyanate (0.45 ml) is added to a solution of 1-(3-mercapuopropanoyl)-L-proline (1 g) in a mixture of N sodium hydroxide (5 ml) and pyridine (5 ml). Tiie solution is heated at 40° for four hours and concentrated in vacuo.
The residue is distributed between 0.1 N hydrochloric acid and ethyl acetate. The organic layer is washed with water, dried over magnesium sulfate and concentrated to dryness to yield 1-(3-([(ethylamino)carbonyl]thio]propanoyl]-L-prolino.
The dicyclohexylammonium salt is prepared by adding dicyclo20 hexylamine to a solution of the free acid in ethyl acetate, m.p. 150-152°.
Example 66 1-{3-[((Ethoxy)carbonyl]thioi-2-niCtay) propunoy1]-L-uroling substituting 1-(3-mercapto-2-methylpropanoyl)-L-proline 3-mercaptopropanoyl-L-proline in the procedure of 58,1-(3-[[(ethoxy)carbonyl)Linoj-2-meLhyiprop.moy1)-Lis obtained.
By for the Example proline -4544707 • Example 67 1-[3-[[(Ethoxy)carbonyl]thiolbutanoyl]-L-proline By substituting 1-(3-mercaptobutanoyl)-L-proline for the 3-mercapfcopropanoyl-L-proline in the procedure of Example 58, 15 (3-([(ethoxy)carbonyl]thio]butanoylj-L-proline is obtained.
Example 6S 1-[3-(((Ethoxy)thiocarbonylIthio]propanoyi)-L-azetidine-2carboxylic acid • By substituting L-azetidine-2-carboxylic acid for L-proline in the procedure of Example 59, 1-[3-([ (ethoxy)thiocarbonyl]thio]propanoyl]-L-azetidine-2-earboxylie acid is obtained.
Example 69 1-[3-[[(Ethoxy)thiocarbonyl·)thio]propanoyl]-L-pipccolic acid By substituting L-pipecolic acid for L-proline in the procedure of Example 59, 1-(3-[[ (ethoxy)thiocarbonyl]thio]propanoyl]-L-pipecolic acid is obtained.
Example 70 1-(4-([(Benzylthio)carbonyl]thio]butanoylJ-L-proline 2° By substituting 4-aiercaptobutanoyl—L-proline for the 3mercaptopropanoyl-L-proline in the procedure of Example 60, 1(4-(ί(benzylthio]carbonyl]thio]butanoyl]-L-proline is obtained.
Example 71 1-(2-(ί(Benzylthio)carbonyl) thio]propanoyl]-L-proline By substituting 2-mercaptopropanoyl-L-prolinc for the 3mercaptopropanoyl-L-proline in the procedure of Example 60, 1[2-(((benzylthio)carbonyl]thio]propanoyl]-L-proline is obtained. •464470 • Example 72 1- [3- [ j (Etiiy 1 ti:loi thiocarbonyl) fchiolpropanoyl} -L-proline methyl ester A solution of 1-[3-{((ethylthio)thiocarbonyl]thio]propanoylJ L-proline in ethyl aootate is treated with an ethereal solution or diazomethane until persistent yellow color. After discharging the yellow color with a few crops of acetic acid, the solvents are removed in vacuo to yield 1-[3-[[(ethylthio)thiocarbonylJthio]propanoyi]-L-proline methyl ester.
Example 73 1-(3-[((methyiaiaino)thiocarbonyl]thio]propanoyl]-5-hydroxy-Lpipecolic acid ay substituting 1-ί3-jnercaptoproponoyi)-5-hydroxy-L-pipecolic acid for the 3-mercaptopropanoyl-L-proline in the Procedure ii of Example 64,1-(3-[[(metnyiamino)thiocarbonylj thio]propanoyl]15 5-hydroxy-L-pipecolic acid is obtained.
Example 74 1-[3-{[(Methylamino)thiocarbonyl]thio]-2-methylpropanoyl]-Lproline amide By substituting 1-(3-mercapto-2-methylpropanoyl)-L-proline 20 amide for the 3-mercaptopropanoyl-L-proline in the Procedure B of Example 64, 1-(3-] [ (methylamino)thiocarbonylJ thio]-2-methylpropanoyl ]-L-proline amide is obtained.
Example 75 1-[3-([(Phcnoxy)carbonyi]thio]propanoyl]-L-proline By substituting phenylchloroformate for ethyl ohioroformate in the procedure of Example 58,l-[4-[[ .uhenoxy)carbonyl]thio)propanoylJ-L-proline is obtained. -zlV' Example 76 1-[3-[[(Phenoxy)carbonyl]thiolbutanoyl]-L-proline By substituting phenylchloroformata for the ethyl chloroformate and 4-mercaptobutanoyl-L-proline for the 3-raercaptopropanoyl-L-proline in the procedure of Example 58, 1- [3-[[(phenoxy)carbonyl]thiolbutanoyl]-L-proline is obtained.
Example 77 1-(3-(((Phenylamino)carbonyl]thio]propanoyl1-L-proline By substituting phenylisocyanate for the ethylisocyanate in the procedure of Example 65,1-(3-([(phenylamino)carbonyl]thio]propanoyl]-L-proline is obtained.
Example 78 1-(3-(((Phcnothylamino)carbonyl]thioIpropanoyl]-L-proline By substituting phenethylisocyanate for the ethylisocyanate in the procedure of Example 65, 1-(3-[[(phenethyiainino)carbonyl]thiolpropanoyl]-L-proline is obtained. example 79 ι 1-[3-[f(Ethylamino)carbonyl]thio]-2-benzylpropanoyl]-L-proline >Q By substituting 1-(3-mercapto-2-benzylpropanoyl)-Lproline for the 1-(3-raercaptopropanoyl)-L-proline in the procedure of Example 65, 1-[3-[[ (ethylamino)carbonyl]thio]2- benzylpropanoyl]-L-proline is obtained. -4844707 Example 8C 1- (3-Mcthylthlopr:.t-anoyl) -L-prolino A) Methyl 3-methylthiopropionace (51 g) is saponified with a 10% sodium hydroxide solution (15C mi, 30 minutes at 100°).
The cooled solution is extracted with ether and then acidified. The crude acid thus obtained is distilled and converted to the acid chloride with thionyl chloride.
A solution of L-proline (11.5 g) in M sodium hydroxide (100 cc) is chilled in an ice bath and the 3-methyichiopropanoic acid chloride (6.3 gj is added dropwise with vigorous stirring over a ten minutes period. After five hours the reaction mixture is acidified and extracted with ethyl ether to yield' 1-(3methyithiopropanoyl)-L-proline. The dicyclohexylammonium salt is prepared by adding dicyclohexylamina to a solution of the free acid in ethyl acetate, m.p. 169-171°.
B) Methyl iodide (71 gj is added to a solution of 1-(3mercaptopropanoylj-L-proline ethyl ester ¢115 g) and sodium (11.5 g) in ethanol (·1ϋ0 mi). The reaction is allowed to proceed overnight, the ethanol is removed in vacuo and the ?(< residue is dissolved in a mixture of ethyl acetate arid water.
The organic layer is dried and concentrated to dryness 1n vacuo. The resulting 1-(3-methylthiopropanoyl)-L-proline ethyl ester (93 gj is suspended in a mixture of methanol (200 ml) and 5 N sodium nydroxide (200 mi) and stirred at room temperature for 2g five hours. The methanol is removed in vacuo, and the aqueous phase is extracted with ethyl acetate, acidified and rcextracted with ethyl acetate. This last organic.phase is washed with water, dried anti concentrated to dryness to yield 1 - (3-nictliy 1 th io propanoyl)-L-proline. -τ * Example 81 1- [3- (4-Chlorophmty I lliio) propanoyl 1 -L-prolinc Aqueous 2 ti sodium hydroxide (25 ml) and 3-bromopropionyl chloride (8.5 g) are added to a solution of L-prolmc (5.75 g) in N-sodium hydroxide (50 mi) chilled and stirred in an ice bath. After five minutes, the ice bath is removed and the stirring is continued for three hours at room temperature. The reaction mixture is acidified with concentrated hydrochloric acid and extracted with ethyl acetate. The organic layer is washed with water, dried and concentrated to dryness in vacuo. The residue is dissolved in a mixture of 4-chlorobenzenethiol (8 g) , sodium hydroxide (4.2 g) and ethanol (300 ml). The solution is refluxed for 6 hours. The'solvent is removed in vacuo and the residue is dissolved in water, acidified with concentrated hydrochloric acid and extracted with ethyl acetate. The organic layer is washed with water, dried, and concentrated to dryness in vacuo to yield 1-(3-(4-chlorophenylthio)propanoyl]-L-proline.
Example 82 1-[((3-Benzylthiomethyl)thio]propanoyl]-L-proline 1-(3-Mercaptopropanoyl)-L-proline ¢8.1 g) is dissolved in boiling liquid ammonia (100 ml) and small pieces of sodium are added until permanent blue color is obtained which is then discharged with a small piece of ammonium chloride. Benzylthiomethyl chloride (5.9 g) is added and the ammonia is allowed to evaporate. The final traces of ammonia are removed in vacuo, the residue is dissolved in water and extracted with ethyl acetate. The aqueous phase is acidified with concentrated hydrochloric acid and extracted with ethyl acetate. The organic layer is washed with water, dried and concentrated to dryness -5044707 . to yield ί-ίί(3-benzylthiomethyl)thiojpropanoyll-L-proline.
Example 83 1-ί ί(3-Acetamidomethyl)thiojpropanoylj-L-proline 1-(3-Mercaptopropanoyl)-L-proline (2 g) and N-hydroxy5 methylacetamide (0.33 g) are dissolved in trifluoroacetic acid (10 ml) and the solution is stored at room temperature for one hour. Tha excess trifluoroacetic acid is removed in vacuo and the residue is precipitated several times from ether-hexane. Finally, the residue is distributed between dilute hydrochloric acid and ethyl acetate. The organic layer is washed with water, dried and concentrated to dryness to yield 1-([ (3-acetamidomethyl) thio j propanoyl]-L-proline.
Example 84 1-(Methylthioacetyl)-L-proline By substituting methyl methylthioacetate for the methyl 3-methylthiopropionate in the Procedure Λ of Example 80, 1(methylthioacetyl)-L-proline, m.p. 123-124°, is obtained.
Example 85 1-(Benzylthioacetyl)-L-proline By substituting benzylthioacetyl chloride for the 3-mcthylthiopropanoyl chloride in the Procedure Λ of Example 80, 1(benzyithioacetyl)-L-proline, m.p. 36-88°, is obtained. -51«4707 Example 86 1-[3-[(2-Phenylethyl)thio]propanoyl]-L-prolinc By substituting phenethylbromide for the methyl iodide in the Procedure B of Example 80, 1-(3-((2-phenyiethyl)thiojpropanoylj L-proline is obtained.
Example 8? 1-[3-[(Triphenylmethyl)thioj propanoyl]-L-prolino By substituting triphenylmethyl chloride for the methyl iodide in the Procedure B of Example 80, 1-[3-[(triphenylmethyl)1θ thio]propanoylJ-L-proline is obtained.
Example 88 1-(3-Methylthio-2-methylpropanoyl)-L-proline amido By substituting 1-(3-mercapto-2-methylpropanoyl)-L-proline amide for the 1-(3-mercaptopropanoyl)-L-proline ethyl ester in the Procedure B of Example 80 and eliminating the saponification step, 1-(3-rnethylthio-2-methylpropanoyl)-L-proline amide is obtained.
Example 89 1-(3-Methylthiopropanoyl)-L-azetidine-2-carboxylic acid 20 By substituting L-azetidine-2-carboxylic acid for the Lproline in the Procedure A of Example 80, 1- {3-methylth.iopropanoyl) L-azetidine-2-carboxylio acid is obtained. -5244707 • Example 90 1-13-(4-Mothoxyphenylthio)propanoyl]-L-proline By substituting 4-methoxybenzenetr.iol for the 4-chlorobenzenethiol in the procedure of Example Si, i-(3-(«l-methoxy5 phenylthio)propanoyl]-L-proline is obtained.
Example 91 1-ί3-Methylthiopropanoyl)-L-pipecolrc acid By substituting L-pipecolic acid for the L-proline in the Procedure A of Example i>G, 1-(3-methylthiopropanoyl)-L-pipecolic C acid is obtained.
Example 92 1-(2-(4-Chlorophonyithio)propanoylj-LproIi»c By substituting 2-bromopropionyl chloride for the 3bromopropionyl chloride in the procedure of Example 81, ΙΕ [2-(4-chlorophenylthio)propanoyl]-L-proline is obtained.
Example 93 J — [ 3— f -(Pi ph enyImothy 1 i tl; i o J -2-oenzy Iprop.n'mvl) )-1.-) n.'o i. ι m· Diphenylmethanol (C.92 g) and 1-(3-mercapto-2-benzylpropanoyl) L-proline (1.5 g) are dissolved in trifluoroacetic acid (10 ml) and the solution is kept at room temperature for 30 minutes. The excess trifluoroacetic acid is removed in vacuo to yield 1-[3[(diphenylmethyl)thio]-2-benzylpropanoyl]-L-proline. -hy• Example 94 1-[4-(4-Chlorophenylthio)butanoyl]-L-proline By substituting 4-bromopropionyl chloride for the 3-bromopropionyl chloride in the procedure of Example 81,1-(4-(45 . chlorophenylthio)butanoyl]-L-proline is obtained.
Example 95 1~(3-[(Benzylthiomethyl)thio]butanoyl]-L-proline By substituting 3-mercaptobutanoyl-L-proline for the 3-mercaptopropanoyl-L-proline in the procedure of Example 82, 1-[3-[(benzylthiomethyl)thio]butanoyl]-L-proline is obtained.
Example 96 1~([4-[(Acetamidomethyl)thio]-2-methylbutanoyl]-L-proline By substituting 1-(4-mercapto-2-methylbutanoyl)L-proline for the 1-(3-mercaptopropanoyl)-L-proline in the procedure of Example 83, l-([4-(acetamidomethyl)thio]-2methylbutanoyl]-L-proline is obtained.
Example 97 1-13-(Kthyirlithio)propanoyl1-L-proline A) 3-Mercaptopropanoyl-L-proline (10 y) is added to a ;0 solution of ethylthiosulfinate (8.4 g) in methanol (100 ml) and the reaction mixture is stirred vigorously at • room temperature for four hours. The methanol is removed in vacuo to yield 1-(3-ethyldithiopropanoyl)-L-proline.
B) A solution of ethylthiosulfinate (8.4 g) in ethanol (5O‘-ml) is added to an aqueous solution of 3-mercaptopropanoyl-L-proline (10 g) maintained at pH C-7 by careful addition of sodium hydroxide. The mixture is stirred vigorously -54447 07 • at room temperature until negative thiol reaction. The mixture is diluted with water, adjusted to pil 8 and extracted with ethyl acetate, tha aqueous phase is acidified to pH 3 and extracted again with ethyl acetate. This latter extract is washed with water, dried and concentrated to dryness to yield 1- [3-(ethyldithio)propanoyl]-L-proline.
Example 9S l-[3-i (4--Methylphenyl)dithio]propanoylI-L-proline A solution of 4~metiylphenylsulfenyl chloride ¢1.76 g.) 1Q in ether (20 ml) is added to a solution of 3-mercaptopropanoyiL-proline (2 g) in 0.5 K sodium hydroxide (20 mi) chilled in an ice bath. The mixture is stirred vigorously for one hour, and the aqueous phase is separated, acidified with concentrated hydrochloric acid and extracted with ethyl acetate. The organic phase is washed v/ith water, dried and concentrated to dryness to yield 1-((3-(4-methylphenyl)dithio]-propanoyl]-L-proline.
Example 99 1-(3-(Phenyldithio)propanoyl)-L-proline By substituting phenylthiosulfinate (prepared from phenyl20 disulfide according to U. Weber and P. Hartter, Z. Physiol. Chem., 351, 1384 (1970)J for the ethylthiosulfinate in the procedure of Example 97,1-(3-(phenyldithio)propanoyl]-L-proline is obtained.
Example 100 1-(3-((2-phonylethyl)dithio]propanoyli-L-prolinc rg By substituting 2-pnenylethylthiosulfinate (prepared from phenethyldisulfide) for the ethylthiosulfinate in the procedure of Example 97, l-[3-[(2-phenylethyl)dithio)propanoyl]-L-proline is obtained.
• Example 101 1-[3-[(2-Hydroxyethyl)dithio]propanoylj-L-proline To a solution of 1,11-ί(sulfinylthio)-bis-(3-propanoyl)]bis-L-proline (21 g) in methanol (100 ml), mercaptoethanol (4,2 g) is added and the reaction mixture is stirred virorously at room ~ temperature for four hours. The methanol is removed in vacuo and the residue is purified by chromatography on a silica gel column to yield 1-[3-[(2-hydroxyethyl)dithio]propanoyl]-L-proline.
Example 102 1-[2-(Ethyldithio)propanoylJ-L-proline By substituting 2-mercaptopropanoyl-L-proline for 3mercaptopropanoyl-L-proline in the procedure of Example 97, 1-[2-(ethyldithio)propanoyl]-L-proline is obtained.
Example 103 (3- [(4-MethylphenyI)dithiolbutanoy] l-L-prolinc By substituting 3-mercaptobutanoyl-L-proline for the 3mercaptopropanoyl-L-proline in the procedure of Example 98, 1-(3-(4-methylphenyl)dithiolbutanoyl)-L-proline is obtained.
Example 104 1-(3-(Ethyldithio)-2-methylpropanoylj-L-proline methyl ester By substituting 1-(3-mercapto-2-methylpropanoyl)-L-proline for the 3-mercaptopropanoyl-L-proline in the procedure of Example 97 and then treating the product with ethereal cliazomethane as in the procedure of Example 72, 1-[3-(ethyldithio)-2-methylpro25 panoyl)-L-proline methyl ester is obtained. -564470? 1-[3-(Ethyldi thio) propanoylj -L~azetidf r.e-2-car boxy lie acid By substituting 3-mercaptopropanoyl-L-nzetidine-2-carboxylic acid for the 3-mercaptopropanoyl-L-prolino in the procedure of Example 97,1-(3-(ethyldithio) propanoylj-L-azetidine-2-carboxylio acid is obtained.
Example 106 1-(3-((4-Methylphonyl)ditbloj-2-methylpropanoylj-L-hydroxyproline By substituting 1-(3-mercapto-2-methyiuropanoyl)-L-hydroxy proline for the 3-mercaptopropanoyl-L-proline in the procedure of Example 98, 1-(3-[i4-methylphenylidithio]-2-methylpropanoyl]L-hydroxyproline is obtained.
Example 107 1- [4- (Ethyldithio)butanoyl!-L-pipecolic acid By substituting 4-mercaptobutanoyl-L-pipecolic acid for the 3-mercaptopropanoyl-L-proline in the procedure of Example 97, 1-[4-(ethyldithio)butanoyl]-L-pipecolic acid is obtained.
Example 108 1- (3-(Ethyldithio)propanoyl]-5-hydroxy-L-pj.pecol ic acid sy substituting 1-(3-mercaptopropanoyl)-5-hydroxy-L-pipecolic acid for the 3-mercaptopropanoyl-L-proline in the procedure of Example 97, 1-(3-(ethyldithio)propanoyll-5-hydroxy-L-pipecolic acid is obtained. -57* «4707 Example 105 γ 1-[3-I (2-Amino-2-carboxyethyl) di.thipl propanoylI-L-proIino A 0.5 H solution of thiocyanogen in glacial acetic acid is prepared by shaking for ten minutes in a sealed flask 600 mg - 5 of dry lead thiocyanate ivith a solution of 75 ul of bromine in 3 ml of acetic acid. After removal of lead bromide and excess lead thiocyanate by centrifugation, 2.5 ml of this solution is mixed with 2.5 ml of a 0.41 M solution of cysteine hydrochloride previously neutralized ivith dilute sodium hydroxide. This mixture is immediately added to 0.75 ml of a 1.9 :-i solution of 3-mercsptopropanoyl-L-proline previously neutralized with dilute sodium hydroxide. After twenty minutes the mixture is titrated to incipient brown color with alcoholic iodine, and adjusted to pH 3. The precipitate is removed by filtration and the filtrate is applied to a column of cation exchange resin (Dowex 50). The column is washed with water until no more acidic material is removed and then eluted with pyridine-acetate buffer pH 6.0.
The fractions containing the disulfide of cysteine and 3mercaptopropanoyl-L-proline are pooled and concentrated to dryness.
Example 110 1,1'-[Dithiobis(3-propanoyl)1-bis-b-proline 3-Mercaptopropanoyl-L-proline (0.95 g) is dissolved in water (20 ml) and the pH is adjusted to G.5 with N-scdium hydroxide. An ethanolic solution of iodine is added dropwise while maintaining the pH at 6.5 with careful addition of N sodium hydroxide. When a permanent yellow color is obtained the addition of iodine is stopped and the color -58^4707 is discharged with i small amount of sodium thiosulfate.
The reaction mixture is acidified with concentrated hydrochloric acid and extracted with ethyl acetate. The organic phase is washed with water, dried and concentrated to dryness to yield 1,1’-(dithiobis(3-prcpanoyl)3-bis-L-proline. The dicyclohexylammonium salt is prepared by addition of dicyclo'hexylamine to a solution of the free acid in acetonitrile, m.p. 175-180°.
Example 111 1,1'- [Pithiobis (2-D-r.iethyI-3-propanoyl) ]-bis-L-proline By substituting 3-mercapto-2-D-methylpropanoyl-Loroline for the 3-mercaptopropanoyl-L-proline in the procedure of Example 110, 1,1'-[dithiobis(2-D-methyl-3-propanoyl)]-bisL-proline is obtained, m.p. 236-237°.
Example 112 1,1'- [Dithiobis(2-propanoyl)-bis-L-proline By substituting 2-raercaptopropanoyl-L-proline for the 3-mercaptopropanoyl-L-proline in the procedure of Example 110, 1,1'-[dithiobis(2-propanoyl)]-bis-L-proline is obtained.
Example 113 1,1'-(Dithiobisacetyli-bis-L-hydroxy proline By substituting 1- (2-mercaptoacetylj-L-hydroxyproline for the 3-mercapfcopropionyl-L-proline in the procedure of Example 110, 1,1'-(dithiobisacetyl)-bis-L-hydroxyproline is obtained.
Example 114 1,1'-(Dithiobisacetyl)-bis-L-azetidine-2-carboxylic acid By substituting 1-(2-mercaptoacetyl)-L-azetidine-2carboxylic acid for the 3-mercaptopropanoyl-L-proline in the procedure of Example 110, 1,1'-(dithiobisacetyl)-bis-Lazetidine-2-carboxylic acid is obtained. 59Example 115 1,1'-[Dithiobis(3-propanoyl)3-bis-L-pipecolic acid By substituting 3-mercaptopropanoyl-L-pipecolie acid for the 3-mercaptopropanoyl-L-prolin-3 in the procedure of 5 Example 110, 1,1’-[dithiobis(3-propanoyl)]-bis-L-pipecolic acid is obtained.
Example 116 1,1'-[Dithiobis(3-propanoyl)]-bis-4-methyl-L-prolinc 1.0 By substituting 1-(3-mercaptopropanoyl}-4-methyl-L-proline for the 3-mercaptopropanoyl-L-proline in the procedure of Example 110,1,1'-(dithiobis(3-propanoyl)]-bis-4-methyl-L-proline is obtained.
Example 117 1,1'-[Dithiobis(3-propanoyl)]-bis-5-hydroxy-L-pipecolic acid By substituting 1-(3-mercaptopropanoyl)-5-hydroxy-L-pipecolic acid for the 3-mercaptopropanoyl-L-proline in the procedure of Example 110,1,1'-[dithiobis(3-propanoyl)]-bis-5-hydroxy-L-pipecolic acid is obtained.
I 20 Example 118 1,11 -[dithiobis(2-benzyl-3-propanoyl)J-bis-L-prolinc By substituting 1-(3-mercapto-2-benzylpropanoyl)-L-proline for the 3-mercaptopropanoyl-lr-proline in the procedure of Example 110, 1,1'25 [dithiobis(2-benzyl-3-propanoyl)3-bis-L-proline is obtained. -63Dxamole r!9 1,1'- ί Dithiobis (2-me inyl-3-propanoyl) j -bis-L-pipeeolic acid By substituting I- (3-mercapto-2-ir.ethylpropanoyl) -L-pipecolic acid for the 3-raersaptopropaneyl-L-prolinc in the procedure of Example 110,1,1'-[dithiobis(2-methyl-3-propanoyl)]-bis-L-pipecolic acid is obtained.
Example 120 1,11 -[Dithiobis(4-butanoyl)]-bis-L-proline By substituting 4-;.iercaptobutanoyl-L-proIine for the 3-mercaptopropahoyl-L-proline in the procedure of Example 110» 1,1'-[dithiobis(4-butanoyl)j-bis-L-proline is obtained.
Example 121 1,11 -[Citniobrs(2-benzyl-4-butanoyl)J-bis-L-proline By substituting 1-(4-mercapto-2-benzylbutanoyl)-L-proline for the 3-mercaptopropanoyl-L-proline in the procedure of Example 110,1,1'-[dithiobis(2-benzyl-4-butanoyl)]-bis-L-proline is obtained.
Example 122 1,1'-[Dithiobis(3-butanoyl)]-bis-L-prolino By substituting 3-mercaptobutanoyl-L-proline for the 3-mercaptopropanoyl-L-proline tn the procedure of Example 110,l,l'-[dithiobis(3-butanoyl)]-bis-L-proline is obtained. _ 61 - 447©?’ • Example 123 1,1'-[Dithiobis(3-propanoyl)[-bis-L-proline methyl ester Λ solution of 1,1'-[dithiobis(3-propanoyl)j-bis-L-proline in methanol is treated v/ith ethereal diazomethane until per5 sistent yellow color. After fifteen minutes a few drops of acetic acid are added and the solvents are removed in vacuo to yield, 1,1'-[dithiobis(3-propanoyl)j-bis-L-proline methyl ester.
Example 124 1,1'-[Dithiobis(3-propanoyl))-bis-L-proline amide A solution of 1,1'-[dithiobis(3-propanoyl)j-bis-L-proline methyl ester in methanol is saturated with ammonia while cooling in an ice-water bath. The reaction mixture is stored for 16 hours at room temperature in a pressure bottle, and then the solvents are removed in vacuo to yield 1,1'-[dithiobis(3-propanoyl)] bis-L-proline amide.
Example 125 1,1[Dithiobis [2-phenyl-3-propanoyl)]-bis-L-proline By substituting 1-(3-niercapto-2-phenylpropanoyl)-L-proline for the 3-mercaptopropanoyl-L-proline in the procedure of Ex20 ample-110,1,1'- [dithiobis(2-phenyl-3-propanoyl)]-bis-L-proline is obtained. - 62.44707 Example 126 1,11 - ί (Sulfinylthio: Lis-; 3-propanoy 1 i j -bis -1.-pro fine While cooling in an icc bath 0.12 mole of peracetic acid is added to a stirred solution of 1,1'-[dithiobis(3-propanoyl)]bis-L-prolinc (40 g) in glacial acetic acid ¢500 ml). The reaction mixture is allowed to stand overnight at room temperature and the solvent is then removed m vacuo to yield 1,1'-((sulfinylthio)-bis-(3-propanoyl)J-bis-L-prolino.
Example 127 1,11 -[(Sulfonyl thio)-bis-(3-propanoy1)i-bin-I.-prolinc A 30% solution of hydrogen peroxide ¢2.0 ml) is added to a solution of 1,1'-[dithiobis(3-propanoyl)]-bis-L-proline (4 g) in glacial acetic acid (80 ml) and the solution is stored for thirty hours at room temperature. The solvent is removed in vacuo to yield 1,1(sulfonylthio)-bis-(3propanoyl)]-bis-L-proline.
Example 12S 1,1' - j (sulfinylthio) -bis-(2-oropar.oyl) ]-bis-L-proline ’By substituting 1,11- [dithiobis(2-propanoyl)]-bis-L-proline for the. 1,11-[dithiobis(3-propanoyl)]-bis-L-proline in the procedure of Example 126,1,1'-[(sulfinylthio)-bis-(2-propanoyl)J bis-L-proline is obtained. -65· » Example 129 !,!'-[(Sulfinylthio)-bis-acetyl3-bis-L-azctidinc-2-carboxylie acid By substituting l,l’-(dithiobisacetyl)-bis-L-azetidine carboxylic acid for the 1,1'-[dithiobis(3-propanoyl))-bis-L5 proline in the procedure of Example 126, 1,1'-1(Sulfinylthio)-bisacetyl ]-bis-L-azetidine-2-carboxylie acid is obtained.
Example 130 1,11-[(Sulfinylthio)-bis-(3-propanoyl))-bis-4-me thyi-L-proline By substituting 1,1'-[dithiobis(3-propanoyl)]-bis-4-methyl10 L-proline for the 1,1'-[dithiobis(3-propanoyl)]-bis-L-proline in the procedure of Example 126,1,1'-[(Sulfinylthio)-bis-(3propanoyl)]-bis-4-methyl-L-proline is obtained.
Example 131 !,!'-[(Sulfinylthio)-bis-(2-benzyl-3-propanoyl)]-bis-L-prolino By substituting l,l'-[dithiobis(2-benzyl-3-propanoyl))-bisL-proline for the 1,1'-[dithiobis(3-propanoyl)]-bis-L-proline in the procedure of Example 126,1,1'-[(sulfinylthio)-bis-(2-benzyl3-propanoyl)]-bis-L-proline is obtained.
Example 132 1,1'-ί(Sulfinylthio)-bis-(4-butanoyl)J-bis-L-proline By substituting 1,1'-[dithiobis(4-butanoyl))-bis-L-proline for the 1,1'-(dithiobis(3-propanoyl)]-bis-L-proline in the procedure of Example 126,l,l1-[(sulfinylthio)-bis-(4-butanoyl)]bis-L-proline is obtained. —64— 44?0γ Example 133 1,11 —[(Sulfinyl thio]-bis-i 3-butanoyl)j-bis-L-proline By substituting 1,1'-[dithiobis(3-butanoyl;j-bis-L-proline for the l,l'-[dithiobis(3-propanoyi)]-bis-L-proline in the pro, cedure of Example 126, 1,1ί(sulfinylthio)-bis-(3-butanoyl)]-bisL-proline is obtained.
Example 134 1,11-ί(Sulfinyl thio)-bis-<2-methyl-3-propanoyli-bis-L-proline By substituting 1,1'-[dithiobis(2-methyl-3-propanoyi)]-bisL-proline for the 1,1*-[dithiobis(3-propanoyl)]-bis-L-proline in the procedure of Example 12iS,i,i‘-[(sulfinylthio)-bis-(2methyl-3-propanoyl)]-bis-L-proline is obtained.
Example 135 1,1'-[(Sulfinylthio)-bis-(2-pheny1-3-propanoyl)j-bis-L-proline By substituting 1,11 -[dithiobis(2-phenyl-3-propanoyi)]-bisL-proline for the 1,11 -[dithiobis(3-propanoyi)]-bis-L-proline in the procedure of Example 126, l,l'-[(sulfinylthio)-bis-(2-phenyl3-propanoyl))-bis-L-proline is obtained.
Example 136 2- [3-[[3-(2-Carboxy-lypyrrolidinyl)-3-oxopropyi]-dithio]-2methylpropanoyl]-L-proline By substituting !,!'-[(sulfinyIthio)-bis-(2-methyl-3propanoyi)]-bis-L-proline for the ethylthiosuifinate in the procedure of Example S7, 1-[3-[[3-(r-carboxy-l-pyrrolidinyl)3- oxopropylj-dithio]-2-methylpropanoyl]-L-proirne is obtained. -t>5Example 137 (Sulfonyltliio)-bis-acetyl)-bis-b-hydroxyproline By substituting l,l'-(dithiobisacetyl)-bis-L-hydroxy proline for the 1,1'-(dithiobis(3-propanoyl)-bis-L-proline in ci;e procedure of Example 127,1,1'-[(sulfonylthio)-bis-acetyl)-bis-Lhydroxyproline is obtained.
Example 138 ^I'-USulfonylthiol-bis-P-propanoyl) 1-bni-b-pipocol ic aciri By substituting 1,1’-[dithiobis(3-propanoyl)j-bis-Lpipecolic acid for .the 1,1'-[dithiobis(3-propanoyl)]-bis-Lproline in the procedure of Example 127,l,l'-[(sul£onylthio)bis-(3-propanoyl))-bis-L-pipecolic acid is obtained.
Example 139 1,11 -[(Sulfonylthio)-bis-(3-propanoyl))-bis-5-hydroxy-L-pipecolic acid By substituting 1,1'-[dithiobis(3-propanoyl)]-bis-5-hydroxyL-pipecolic acid for the 1,1'-[dithiobis-(3-propanoyl)J-bis-Lproline in the procedure of Example 127, 1,1'-[(sulfonylthio)-bis(3-propanoyl)]-bis-5-hydroxy-L-pipecolic acid is obtained.
Example 140 1,1'- [ (Sulfonylthio)-bis-(2-methyl-3-propanoyI)]-bis-L-pipecolic acid .
By substituting 1,1'-[dithiobis(2-methyl-3-prouanoyl)]-bisL-pipecolic acid for the 1,1[dithiobis{3-propanoyl)]-bis-Lβ proline in the procedure of Example 127,1,1ί(sulfonylthio)-bis· (2-methyl-3-propanoyl) ]-b Lu-Ι,-ρ i.pueu I i.o acid is obtained. -6644707 1,1'- ί (Sulfonyit.hioi-bis-{2-bcnzyi-4-butanoyl) ]-bis-L-proline By substituting 1,1'-iditniobis(2-benzyl-4-butanoyljj-bisL-proiine for the 1;1[dithiobis(2-propanoyi)J-bis-L-proline in the procedure of Example 127, 1,1'-ί(suifonyltiiio)-bis-(2-benzyl4-butanoyl)]-bis-L-proline is obtained.
Example 142 3-Acatylthlo-2-phenylpropanoic acid By substituting 2-phenylacrylic acicl for the methacrylic 10 acid in the procedure of Example 25, 3-acetylthio-2-phenylpropanoic acid is obtained, 1-(3-Acetylthio-2-phenyipropanoyl)-L-proline LuLh-butyl ester By substituting 3-acotylthio-2-phenylpropanoic acid for the 3-acetylthio-2-methylprcpanoic acid in the procedure of Example 28, 1-(3-acetylthio-2-phenylpropanoylj-L-proline tort.butyl ester is obtained.
Example 143 1-(3-Mercapto-2-phenylpropanoyl)-L-proline By substituting 1-(3-acetylthio-2-phenylpropanoyl)-L20 proline tert-butyl ester for the 1-(3-acetylthio-2-methylpropanoyl-L-proline tert-butyl ester in the procedure of Example 29, and subjecting the product to ammonolysis as in Example 34, 1-(3-acetylthio-2-phenylpropanoyl)-L-proline and 1-(3-mercapto-2-phenylpropanoyI)-L-proline are obtained. -67. Example 144 1-[3-(Acetylthio)-DL-propanoyljpipecolic acid Pipecolic acid {6.5 g.) is suspended in 200 ml. of dimethylacetamide. 3-acetylthiopropanoyl chloride (8.3 g.) is added dropwise at 23° to the suspension. A clear solution forms and the temperature rises to 28°.
To this clear solution is added N-methylmorpholine (10.1 g.). An immediate precipitate forms and the temperature rises to 34°. The mixture is heated on a steam bath for 1 hour when a clear solution forms. On cooling, the precipitated solid is filtered to yield 5.1 g. of 1-[3-(acetylthic)-DLpropanoyl]pipecolic acid, m.p. 190-200°. The solvent is removed and the viscous residue is triturated with isopropyl ether to yield 7.8 g. of product, m.p. 98-101°. Recrystalliza15 tion from acetone-hexane yields a constant melting solid, m.p. 102-104°; Rf 0.72 [silica gel, benzene, acetic acid (7:2)] Example 145 DL-1-(3-Mercaptopropanoyl)pipecolic acid ml. of concentrated ammonium hydroxide is stirred under nitrogen at 10° for about 15 minutes, then solid 1-[3-(acetylthio)-DL-propanoyl]-pipecolic acid (6.6 g.) is added at 5 to 10°. A clear solution forms after 2-3 minutes. The ice bath is removed and the solution is stirred at room temperature under nitrogen for 45 minutes. The solution is made strongly acid with 20% HCl (cooling) and the precipitated oil is extracted with 3 x 150 ml. of ethyl acetate. The ethyl acetate extracts are dried over magnesium sulfate and the solvent is removed to yield 6,0 g. of DL-1-(3-mercaptopropanoyl)pipecolic acid, Rf 0.77 [silica gel, benzene,acetic acid (7:1)]. -6844 707 Example 146 1-(3-Mercaptopropanoyl)-L-pipecolic acid By substituting L-pipecolic acid for the DLpipecolic acid in the procedure of Example 144 and then submitting the product to the procedure of Example 145, 1-[3-(acetylthio)propanoyl]-L-pipecolic acid and 1-(3mer.'aptopropanoyl)-L-pipecolic acid 0.80 [silica gel, benzene, acetic acid (7:1)], [cc,.. -51,5 (c, 1.0 abs.
D ethanol), are obtained.
Example 14? 1- [3-(Acetylthio)-2-methylpropanoyl-· DL-pipecolic acid 6.5 g. (0.05 m.) of pipecolic acid are suspended in dimethylacetamide (200 mg.), S.O g. (0.05 m.) of 3-aoetylthio-2-methylpropanoyl chloride is added dropwise. The temperature rises to 29° and a clear solution forms. Then 10.1 g. of N-methylmorpholine is added all at once and the temperature rises to 34°. The mixture is heated on a steam bath for 1 hour when a clear solution forms.
This is allowed to stand at room temperature overnight and the solid which precipitates is filtered to yield 6.1 g., m.p. 203-204°. The solvent is removed and the viscous residue is triturated with water and 20% HC1. The yellow oil is extracted with 3 x 150 ml. of ethyl acetate. The ethyl acetate extracts are dried over magnesium sulfate and removed to yield 14 g. of 1-[3-(acetylthio)-2-methylpropanoyl-DL-pipecolic acid as a viscous oil.
Example 148 1— (3-M,ercapto-2-methylpropanoyli-DL-pipecolic aoid Aqueous NH^OH (30 ml. water and 20 ml. cone. NH^OH) o is stirred under nitrogen at 10 for 15 minutes. This is „ added to 13.0 g. (0.05 m) of 1-[3-(acetylthio)-2methylpropanoyl]-DL-pipecolic acid and the resulting solution is stirred for 10 minutes under nitrogen; then at room temperature for 50 minutes. It is then treated with water and 20% HCl and the yellow oil extracted with 3 x 150 ml. of ethyl acetate. The ethyl acetate extract is dried over magnesium sulfate and removed to yield 11.1 g. 1-(3mercapto-2-methylpropanoyl)-DL-pipecolic acid as a viscous oil. Rf 0.62 [silica gel, benzene, acetic acid (7:2)]. 1θ > Example 149 3-[(4-Methoxyphenyl)methylthio]-2-methylpropanoic acid p-Methoxy-a-toluene thiol (15.4 g., 0.1 mol.) is added to a solution of methacrylic acid (8.6 g., 0.1 mol.) in 50 ml. 2N sodium hydroxide. The mixture is heated on the steam bath for three hours, then refluxed for two hours and cooled. The mixture is extracted with ether, then the aqueous layer is acidified with concentrated HCl and extracted with dichloromethane. The acidic extracts are washed with brine, dried (MgSO^) and evaporated in vacuo.
The resulting semi-solid is taken up in 50 ml. of dichloromethane, diluted with 50 ml. hexane, and chilled. 3-((4methoxyphenyl)methylthio]-2-methylpropanoic acid is. collected as a white crystalline solid, m.p. 74-82° (5.5 g.).
Example 150 1-[3-(4-Methoxyphenyl)methylthio]-2-methylpropanoyl-Lproline tert-butyl ester 3-[(4-methoxyphenyl)methylthio]-2-methylpropanoic acid (3.6 g., 0.015 mol.), L-proline tert-butyl ester (2.6 g., 0.015 mol.), and dicyclohexylcarbodiimide (3.1 g.. -7044707 . 0.015 mol.) are dissolved in 50 ml. of dichloromethane and stirred thirty minutes at 0°. The cooling bath is removed and the mixture stirred overnight (sixteen hours).
The resulting suspension ia filtered and the filtrate washed with 5ΐ potassium bisulfate, saturated sodium bicarbonate and brine, then dried 'MgSO^) and evaporated in vacuo.
The resulting clear oil is applied to a 250 ml. silica gel column and chromatographed using 20% ethyl acetate/ hexane as eluant. The main fraction (R- = 0.70, silica W gel, ethyl acetate) is evaporated tc 5.5 g. (93¾} of 1[ 3-(4-methoxyphenyl)me fchylthio]-2-methyipropanoyl-L-proIine tert-butyl ester as a clear oil. = 0.70 (silica gel, ethyl acetate); R - 0.60 (silica gel, ether).
Example 151 1- (3-Mercapto~2-methylpropan.oyl)-L-proline The ester from Example 150 (1.2 g., 0.003 mol.), anisole (5 ml.) and trifluoromethanesulfonic acid (0.5 ml.) are dissolved in 20 ml. of trifluoroacetic acid under nitrogen, and the resulting red solution let stand one hour at room temperature. The solution is evaporated in vacuo to a red residue which is taken up in ethyl acetate and washed with water, brine, then dried (MgSO^) and evaporated.
The residue is repeatedly triturated with hexane and the residual hexane evaporated; the oil residue amounts to 0.4 g. A portion (180 mg.) of this material is subjected to preparative thin-layer chromatography on 2 mm silica gel plates using benzene/acetic acid 75:25 as eluant. The main nitroprusside-positive band (R^ - 0.40) is recovered, affording 135 mg. of 1-i3-mercapto-2-methylpropanpyl)-L30 proline as an oil. TLC using benzene/acetic acid 75:25 -7144707 . (Rf = 0.40) and chloroform/methanol/acetic acid 50:40:10 (Rf = 0.62).
Example 152 1-(3-Mercapto-2-D-methylpropanoy1)-L-proline Under a blanket of argon 1-[3-(acetyIthio)-2D-methylpropanoyl]-L-proline (10.0 g.) is slurried in water (150 ml.) at 10°. To this mixture is added 5N sodium hydroxide and the pH of the solution maintained at 13 for 1.5 hours. After this time, when the uptake of sodium hydroxide had ceased, the solution is acidified to a pH = 2.0 with concentrated sulfuric acid.
The aqueous solution is then extracted three times with methylene chloride (3 x 150 ml.) and the combined, methylene chloride fractions concentrated to an oil. The concentrate is taken up in ethyl acetate, filtered and the filtrate diluted with hexane (30 ml.).
An additional amount of hexane is added after 1/2 hour and then the mixture cooled to 10° for 1 hour.
The crystals are filtered and washed v/ith hexane . (2 x 25 ml.) and dried to constant weight to give 1-(3-mercapto-2-D-methylpropanoyl)-L-proline as white crystals, 6.26 g., m.p. 100-102°.
Example 153 1- [3-Tosyloxy-2-methylpropanoyl]-L-proline By substituting 3-tosyloxy-2-methylpropanoic acid chloride for the 3-acetylthio-2-methylpropanoic acid chloride in the procedure of Example 29b 1-[3tosyloxy-2-methylpropanoyl]-L-proline is obtained. -73. Example 154 1-[3-Acetylthio-2-methylpropanoylj-L-proline 1-[3-TosyIoxy-2-methylpropanoylj-L-proline (3.5 g.} is added to a solution of thiolaeetic acid (1.14 g.), and triethylamine (3.5 ml.) in ethyl acetate (20 ml.). The solution is maintained at 50° for three hours, cooled, diluted with ethyl acetate (100 ml.), and washed with dilute hydrochloric acid. The organic layer is dried and concentrated to dryness in vacuo. The residue is dissolved in acetonitrile and dicyclohexylamine is added. The crystalline precipitate is recrystallized from isopropanol to yield 1-[3-acetylthio-2-D-methylpropanoyl)-L-proline, dicyclohexylamine salt, m.p. 187-188°, [«]ρ5 67° (c 1,4, EtOH). This salt is converted to the free acid, m.p. 83-85 (an isomorphic form of m.p. 104-105° is obtained if the crystallizing solution is seeded with high melting material).
Example 155 1-(3-Mercaptopropanoyl)-L-proline, t-butyl ester To a stirred solution of 1.71 g. (10 mmoles) of proline t-butyl ester and 1.35 g. (10 mmoles) of 1hydroxybenzotriazole hydrate in 20 ml. of N,N-dimethylformamide at 0-5° are added 2.06 g. (10 mmole) of N,N'dicyelohexylcarbodiimide. The mixture is stirred for minutes, followed by the addition of 1.06 g. (10 mmole) of 3-mercaptopropanoic acid in 2 ml. of N,N-dimethylformamide- The mixture is then stirred at 0-5° for 1 hour, and at room temperature overnight.
The precipitated Ν,Ν'-dicyclohexylurea is 5θ filtered off, and the filtrate concentrated in vacuo. -73. The residue is taken up in ethyl acetate, washed thoroughly with saturated aqueous sodium bicarbonate, dried, and concentrated in vacuo to 2.5 g. of oil.
The oil is taken up in 1:1 ethyl acetate-hexane 5 and applied to a silica gel column (100 g.). Elution with 1:1 ethyl acetate-hexane affords 1.40 g. (54S) of 1-(3-mercaptopropanoyl)-L-proline, t-butyl ester as an oil, which crystallizes on standing. Recrystallization from ether-hexane yields 0.9 g. of colorless crystalline I . solid, m.p. 55-60°, identical to the compound of Example 17.
Example 156 1-(3-Mercaptopropanoyl)-L-proline A solution o£ 75 mg. (0.27 mmole) of 1-[3-[f(ethyl15 amino)carbonyl]thio]propanoyl]-L-proline in 1 ml. each of concentrated ammonium hydroxide and water is allowed to stand at room temperature for 18 hours under argon. The solution is diluted with a small amount of water and extracted with ether. The aqueous layer is acidified with cold concentrated hydrochloric acid and extracted with ethyl acetate. The combined extracts are dried and concentrated in vacuo to give a compound identical with the product of Example 18. TLC (silica gel; benzene:acetic acid 7:3) R^ 0.4.
Example 157 Methacryloyl-L-Proline L-proline (23.0 g., 0.2 mol.) is dissolved in 100 ml. water and stirred in an ice bath. Methacryloyl chloride (19.6 ml., 0.2 mol.) in 25 ml. of methyl isobutyl ketone is added dropwise over three hours. Sodium hydroxide -7444707 solution (2Nj is added simultaneously, maintaining the pH of the reaction mixture at 7.0. Addition of base is continued for four hours after addition of acid chloride has been completed. The reaction mixture is adjusted to pH 5 with concentrated HC1 and extracted with ethyl acetate. The aqueous layer is then acidified to pH 2.5 and extracted thoroughly with ethyl acetate. The acidic extracts are washed with brine and dried (MgSO,.). The -i ethyl acetate solution is treated with dicyclohexylamine (40 ml.) and chilled overnight. The resulting white precipitate is filtered and dried, yielding 29 g. (39%) of white solid, m.p. 202-210°. The solid is crystallized from 1.5 liters 3:1 acetonitrile/isopropanol to yield 19.7 g. of methacryloyl-L-proline, dicyclohexylamine salt as fine white needles, m.p. 202-210°, The salt is dissolved in water/ethyl acetate and the mixture acidified with concnetrated HCl. The resulting suspension is filtered to remove a fine white precipitate which is washed well with ethyl acetate. The filtrate is saturated with sodium chloride and extracted thoroughly with ethyl acetate. The extracts are washed with brine, dried (MgSO^) and evaporated to a clear oil which solidifies. Crystallization from ethyl acetate/hexane yields 7.5 g. (83%) of methacryloyl-L-proline as a white crystalline solid, m.p. 89-93°. An analytical sample is obtained by recrystallization, m.p. 95-98°.
Example 158 1-(3-Acetylthio-2-i)-methylpropanc/1)-L-proline '· Methacyloyl-L-prolinc (183 mg., 0.001 mol.)- is dissolved in thiolnoetio acid (0.5 mJ.) and allowed -7.54,47 07 to stand at room temperature for sixteen hours. The solution is evaporated in vacuo to a yellov; residue. Preparative thin layer chromatography (silica gel, dichloromethane/methanol/acetic acid 90:5:5) allows isolation of a clear oil (240 mg.) as the main fraction. TLC (dichloromethane/methanol/acetic acid 90:5:5) shows this material to be 1-(3-aeetylthio~2-DL-methylpropanoyl)-L-proline corresponding to the product of Example 29B. Rf = 0.35; (bensene/acetic acid 75:25) R^ = 0.38.
The oil is dissolved in 3 ml. acetonitrile, treated with dicyclohexylamine until the solution is basic, and chilled. A white crystalline solid (106 mg.) m.p. 175-181°, is collected. Crystallisation from isopropanol gives 1-(3-acetylthio-2-D-rnethylpropanoylΙΕ-proline, dicyclohexylamine salt, m.p. 187-188°, identical with this product in Example 29A.
Example 159 1-[Dithiobis-(2-methyl-3~propanoyl)]-bis-L-proline By substituting 3,3'-dithiobis-2-methylpropanoic acid for the 3-acetylthio-2-methylpropanoic acid in the procedure of Example 29B, 1-[dithiobis-(2-methyl-3-propanoyl)Jbis-L-proline is obtained.
Example 160 1-(3-Mercapto-2— methylpropanoyl)-L-proline Zinc dust (10.0 g.) is added to a slurry of the product of Example 159 (5.0 g.) in 100 ml. of l.O.N sulfuric acid and the mixture is stirred at 18° for four hours under a blanket of nitrogen. The solution is then filtered, the zinc washed with water (20 ml.) and the combined filtrates are extracted with methylene chloride - 76(3 χ 75 ml.). The methylene chloride washes are back extracted with water (25 ml.) and then the organic solution concentrated tc an oil. This oil is taken up in ethyl acetate (20 mi.) ar.d filters'.·:. Hexane (15 ml.) is added to the filtrate and the mixture is stirred for 15 minutes. After this time, an additional volume of hexane (30 ml.) is added and the solution cooled to 5° for 1 hour. The mixture is then filtered, and the product is washed with hexane (2 x 10 ml.) and dried to give 4.17 g. of white crystals of the product, l-(3-mercapto-2methylpropancyl)-L-proline. TLC, R = 0.60 (Solvent system: benzene/acetic acid 75:25).
Example 161 3-Benzylthio-2-iBethylpropanoio acid By substituting a-toluenathiol for p-methoxy-atoluenethiol in the procedure cf Example 149, 3-benzylthio-2methylpropanoic acid is obtained.
Example 162 1-[3-(Benzylthio)-2-methylpropanoyl]-L-proline tert. butyl ester By substituting 3-benzylth.io-2-metnylpropanoic acid for the 3-[ (4-methoxyphenyljmethyIthio]-2-methylpropanoic acid in the procedure of Example 150, l-[3(benzylthio)-2-methylpropanoyl]-L-proline tert, butyl ester is obtained.
Example 163 1- [3-(Benzylthio)-2-methylpropanoyl]-L-proline 1-[3-(benzylthio)--2-methylpropanoyl]-L-proline tert, butyl ester (7.8 g.) is dissolved in a mixture of anisole (55 ml.) and trifluoroacetic acid (110 ml.). After -77. one hour storage at room temperature, the solvent is removed in vacuo and the residue is dissolved in ether, washed several times with saturated sodium chloride, dried ι over magnesium sulfate and evaporated to dryness in vacuo 5 to yield 1-[3-(benzylthio)-2-methylpropanoyl]-L-proline. 0.5 (Silica gel, Benzene/acetio acid 3:1) Rf 0.5.
(Silica gel, Methyl-ethylketone/acetic acid/pyridine/water 14:1:2:1).
Example 164 . 1—(3-Mercapto-2-methylpropanoyl)-L-proline 1-[3-(benzylthio)-2-methylpropanoyl]-L-proline (0.1 g.) is suspended in boiling liquid ammonia (10 ml.) and small pieces of sodium are added with stirring until persistent blue color. The color is discharged with a few crystals of ammonium sulfate and the ammonia is allowed to evaporate under a current of nitrogen. The residue is dissolved in a mixture of dilute hydrochloric acid and ethyl acetate. The organic layer is dried and concentrated to dryness in vacuo to yield 1-(3-mercapto-2-methylpropanoyl)L-proline. Rf: 0.35 (Silica gel; Benzene/acetic acid 3:1), 0.5 (Silica gel; Methyl-ethylketone/acetic acid/ pyridine/water 14:1:2:1) identical to the compound of Example 34.
Example 165 3-Triphenylmethylthio-2-methylpropanoic acid · A solution of 3-mercapto-2-methylpropanoic acid (1.2 g.) and tritylchloride (2.9 g.) in methylene chloride (50 ml.) is kept at room temperature for 2 hours.
The mixture is warmed in a steam bath for 20 minutes and then evaporated to dryness in vacuo and the residue is dissolved -784 4707 in saturated aqueous sodium bicarbonate and the solution is washed with ethyl acetate. The aqueous phase is acidified to pH 3 and extracted with ethyl acetate. The organic layer is dried and concentrated to dryness to give 3-triphenylmethylthio-2-methylpropanoic acid. Rf 0.8 (Silica gel, Benzene/acetic acid 3:1).
Example 166 1- [3-(Tripheny1® ethylthio)-2-nieUiylpropanoyl]-L-proline tert.butyl ester By substituting 2-triphenylmethylthio-2~methylpropanoic acid for the 3-[(4-methoxyphenyl)methylthio]2- methylpropanoic acid in tha procedure of Example 150, 1-(3-(triphenylmethyithio)-2~methylpropanoyl]-L-proline tert.butyl ester is obtained.
Example 167 1— -13—(Triphenylmathylthio)-2-methylpropanoyl]-L-proline 3-TriphenyImethylthio-2-methylpropanoic acid * (1.8 g.) and Ν,Ν’-carbonyldiimidazole (1).8 g.) are dissolved in tetrahydrofuran (10 ml.) with stirring at room temperature. After twenty minutes, the solution is added to a mixture of L-proline (0.6 g.) and N-methylmorpholine (1 g.) in dimethylacetamide (20 ml.). The resulting mixture is stirred overnight at room temperature, concentrated to dryness and the residue dissolved in a mixture of ethyl acetate and 10% aqueous potassium bisulfate. The organic layer is separated and dried and concentrated to dryness in vacuo to obtain i-[3™{triphenylmethylthio)2- methylpropanoyl]-L-proline. R^: - 0.4 (Silica gel, Benzene/acetic acid 3:1), :/.. 1.0 (Silica gel, Methy1-ethylketone/acetic acid/pyridine/water 14:1:2:1). -794145707 . Example 168 1-[3-Mercapto-2-methylpropanoyl)-L-proline 1-[3-(triphenylmethylthio)-2-methylpropanoyl]-Lproline tert.butyl ester (5 g.) is dissolved in a mixture of anisole (55 ml.) and trifluoroacetic acid (110 ml.).
After one hour storage at room temperature, the solvents are removed in vacuo and the residue is applied to a column of silica gel equilibrated vzith benzene:acetic acid (75:25) and eluted vzith the same solvent. The Ίθ fractions corresponding to the component vzith R^ 0.40 (TLC silica gel with same system) are pooled and concentrated to dryness to yield 1-[3-mercapto-2-methylpropanoyl)-Lproline. 0.62 (silica gel, chloroform/methanol: acetic acidswater 50:40:10), identical to the compound of Example 34.
Example 169 3-(Tetrahydropyran-2-ylthio)-2-methylpropanoic acid To a solution of 3-mercapto-2-methylpropanoic acid (2.4 g.) and freshly distillled 2,3-dihydro-4H20 pyrane (1.9 g.) in benzene (60 ml.), boron trifluoride etherate (2.8 g.) is added. After two hours, potassium carbonate (4 g.) is added, the mixture is stirred and filtered. The filtrate is concentrated to dryness to yield 3-(tetrahydropyran-2-ylthio)-2-methylpropanoic acid.
Example 170 1-[3-(Tetrahydropyran-2-ylthio)-2-methylpropanoyl]-L-proline By substituting 3- (tetrahydropyran-2-ylthio)-2methylpropanoic acid for the 3-triphenylmethylthio-2methy,lpropanoic acid in the procedure of Example 167, 1- [3- (tetrahydropyran-2-ylthio)-2-methylpropanoyl]-L-proline -8044707 is obtained. 0.8 (Silica gel, Benzene/acetic acid 3:1; R^: 0.73 (Silica gel, Methyl-ethylketone/Acetic acid/ pyridine/water; 14:1:2:1).
Example 171 1-(3-Mercapto-2-methylpropanoyl)-L-proline A solution of 1-[3-(tetrahydropyran-2-ylthio)-2methyipropanoyl)-L-proline (1 g.) in a mixture of methanol (25 ml.) and concentrated hydrochloric acid (25 ml.) is stored at room temperature for 30 minutes. The solvents are removed in vacuo to yield 1-'3-mercapfcc-2-methylpropanoyl)-L-proline. R : 0.35 (silica gel, Benzene/ acetic acid, 3:1), R. 0.5 (silica gel, Methyl-ethylketone/ acetic acid/pyridine/water 14:1:2:1) identical to the compound of Example 34.
Examole 1,2 3-Acetamidometliyithj-i_.-2-msthylpropanoic acid 3-Mercapto-2-methylpropanoic acid (2.4 g.) and N-hydroxymethylacetamide (1.8 g.) are dissolved in trifluoroacetic acid and the solution is stored at room temperature for one hour. The trifluoroacetic acid is removed in vacuo and the residue is dried in vacuo over potassium hydroxide to yield 3-aeetamidomethylthio-2methylpropanoic acid.
Example 173 1- [3-(Acetamiaomethylthio)-2-methylpropanoyl]-L-proline By substituting 3-acetamidomethylthio-2-methylpropanoic acid for the 3-(tetrahydropyran-2-yl thio)-2jnethylpropanoic acid in the procedure of Example 170 1- [3-'(acetamidomethylthio)-244707 methylpropanoylj-L-proline is obtained. Rg 0.2 (Silica gel, Benzene/acetic acid 3:1) Rg 0.3 (Silica gel, Mathylethylketone/acetic acid/pyridine/water 14:1:2:1).
Example 174 1-(3-Mercapto-2-methylpropanoyl)-L-proline 1-[3-(acetamidomethylthio)-2-methylpropanoyl)-Lproline (1.4 g.) and mercuric acetate (1.93 g.) are dissolved in a mixture of acetic acid (25 ml.) and water (25 mi.).
After one hour stirring on the steam bath, hydrogen sulfide is bubbled through until no more precipitation of mercuric sulfide is observed. The mixture is filterd, the precipitate is washed with ethanol, and the filtrate is concentrated to dryness in vaouo to yield 1-(3-mercapto-2-methylpropanoyl)L-proline. Rf: 0.35 (Silica gel, Benzene/Acetio acid 3:1}; Rg : 0.5 (Silica gel, Methyl-ethylketone/Acetic acid/ pyridine/water 14:1:2:1) identical to the compound of Example 34.
Example 175 1-(3-Mercapto-2-methylpropanoyl)-L-proline tert, butyl ester To the cold (5°) solution of 1.2 g. (10 mMol.) of 3mercapto-2-methylpropanoic acid and 1.7 g. (10 mMol.) of L-proline tert, butyl ester in 25 ml. dichloromethane 2.26 g. of dicyclohexylcarbodiimide in 5 ml. dichloromethane is added in portions. After 2 hours at room temperature, drops of acetic acid are added, the mixture is filtered and the filtrate evaporated to an oily residue. This residue is taken up in 20 ml. of petroleum ether-ethyl acetate (3:1) and applied to a 150 ml. silica gel column prepared in petroleum ether. The fraction eluted with petroleum ether-ethyl acetate (1:1) contains the product, -8244707 1-(3-mercapca-2-methylpropanoyl)-L-proline tert.butyl ester. This fraction CO.S g.) is dried over ?-,0,. in vacuo for 12 hours. Rf 0.6 (Silica gel, Benzene/Acetic acid 3:1), Rf 0.8 (Silica gel, Methyl-ethyiketone/acetic acid/pyridine/ water 14:1:2:1), Example 176 1-(3-Mercapto-2-nisthylpropanoyl)-L-proline By substituting 1-(3-mercapto-2-methylpropanoyl)-Lproline tert, butyl ester for the 1-(3-mercaptopropanoyl-Lproline tert.butyl ester in the procedure of Example 18C, l~(3-mercapto-2-methylpropancyl)-L-proline is obtained.
Rf 0.35 (Silica gel, Benzene/acetic acid 3:1), Rf 0.5 (Silica gel, Methyi-ethylketone/Acetic acid/Pyridine/Water 14:1:2:1), identical to the compound of Example 34. -35' ¢470^ The racemic form of the final product in any of the foregoing exami/les is produced by utilizing the DL-form of the starting amino acid instead of the L-form.
Similarly, the D-form cf the final products in any of the foregoing examples is produced by utilizing the D-form of the starting amino acid instead of the L-form.
Example 177 1000 tablets each containing 100 mg. of 1-(2mercaptopropanoyl)-L-proline are produced from the following ingredients: 1-(2-Mercaptopropanoyl)-L-proline 100 g Corn starch . 50 g Gelatin 7-.5 g Avicel (microcrystalline cellulose) 25 g Magnesium stearate 2.5 g The 1-(2-mercaptopropanoylJ-L-proline and corn starch are admixed with an aqueous solution of the gelatin.
The mixture is dried and ground to a fine powder. The Avicel and then the magnesium stearate are admixed with the granulation. This is then compressed in a tablet to form 1000 tablets each containing 100 mg. of active ingredient.
Example 178 By substituting 100 g. of 1-(3-mercapto-2-Dmethylpropanoyl)-L-proline for the 1-(2-mercaptopropanoyl)L-proline in Example 177, 1000 tablets each containing 100 mg. of the 1-(3-mercapto-2-D-methylpropanoyl-L-proline are produced. -8444707 Example 179 1000 tablets each containing 200 ing. of 1-(2mercaptoacetyi)-L-proline are produced from the following ingredients: 1-(2-Mercaptoacetyl)-L-proline 200 g. Lactose 100 g. Avicel 150 g- Corn starch 50 g. Magnesium stearate ij g · The i-(2-mercaptoacetyl)-L-proline, lactose and Avicel are admixed, then blended witn tha corn starch. Magnesium stearate is added. The dry mixture is compressed in a tablet press to form 1000 505 mg. tablets each containing 200 -mg. of active ingredient. The tablets are coated with a solution of Methocel E 15 (methyl cellulose) including as a color a lake containing yellow #6.
Example 180 Two piece #1 gelatin capsules each containing 250 mg. of 1-(2-mercaptopropanoyl)-L-proline are filled with a mixture of the following ingredients: 1-(2-Mercaptopropanoyl)-L-proline 250 mg. Magnesium stearate 7 mg. US? lactose 193 mg. Example 181 An injectable solution is produced as follows: 1-(2-Mercaptopropanoyl)-L-proline 500 mg. Methyl paraben 5 g. Propyl paraben 1 g. Sodium chloride 25 g- Water for injection qs. 5 1.
. The active substance, preservatives and sodium chloride are dissolved in 3 liters of water for injection and then the volume is brought up to 5 liters. The solution is filtered through a sterile filter and aseptically filled into presterilized vials which are then closed with presterilized rubber closures. Each vial contains 5 ml. of solution in a concentration of 100 mg. of active ingredient per ml. of solution for injection.
Example 1θ^ By substituting 100 g. of 1,1[dithiobis(2-D-methyl3-propanoyl)]-bis-L-proline for the 1-(2-mercaptopropanoyl)L-proline in Example 177, 1000 tablets each containing 100 mg. of the 1,1'-[dithiobis[2-D-methyl-3-propanoyl)j-bis-Lproline are produced.
Each of the products of the examples can be Similarly formulated by substituting it for the active ingredient in Examples 177, 179, 180 or 181.

Claims (33)

CLAIMS:
1. A conio&und of the formula (CH) jl CH H 2 C CO R 7 ι 3 (CH) CH-COR wherein R is hyc.roxy, HH^ lower alkoxy; R^ and Rj each is hydrogen, lower alkyl, phenyl or phenyl-lower alkyl; is hydrogen, lower alkyl, phenyl, substituted phenyl wherein the phenyl substituent is halo, lower alkyl or lower alkoxy, phenyl-lower alkyl, diphenyllower alkyl, triphenyl-lower alkyl, lower alkylthiomethyl, phenyl-lower glkylthiomethyl, it i? lower alkanoylamidcmethyl, Rg-C-, R -M-C-, II R -ίίΗ-C-, R.-S- or R_ ; 5 bi r is.hydrogen, hydroxy or lower alkyl; R is lower alkyl, phenyl or phenyl-lower 5 alkyl; R, is lower alkyl, phenyl, substituted phenyl, wherein the phenyl substituent is halo, lower alkyl or lower alkoxy, hydroxy-lower alkyl or amino(carboxy)lower alkyl; (HC)- CII. R, R, m I f 1 R ? is R-OC-HC-- H -—CO — CH — (CH) n -S (0) ; M is 0 or S; m is 1, 2 or 3; n and p each is 0, 1 or 2; or such a compound in the form of.a salt with a base. -87-
2. A compound as in Claim 1 wherein R is hydroxy or lower alkoxy; is hydrogen or lower alkyl; R o rs hydrogen, Rg-CO, Rg-S-, or R ? ; R, and Rj each is hydrogen; r<_ is lower alkyl or phenyl; Rg is lov/er alkyl; if rs R. I P N-CO-CH-(CH) n ~S- wherein R, R^ and R R-OC10 have the same meaning as above; m is 2 and n is 0, 1 or 2.
3. A compound as in Claim 1 wherein R^ and R^ each is hydrogen.
4. A compound as in Claim 1 wherein m is 2 and R^ is hydrogen.
5. A compound of the formula R. R -S- {CH 2 ) — CH - CO — N-1— COR wherein R is hydroxy or lower alkoxy; r^ is hydrogen or lower alkyl; r 2 is hydrogen or lower alkanoyl; n is 0, 1 or 2; or such a compound in the form of a physiologically acceptable salt
6. A compound as in Claim 5 wherein R is hydroxy.
7. A compound as in Claim 5 or 6 wherein n is 1.
8. A compound as in Claim 5, 6 or 7 wherein R 2 is hydrogen or lower alkanoyl.
9. A compound as in Claim 5, 6 or 7 where R 2 is hydrogen.
10. A compound as in Claim 5, 6 or 7 where R 2 is acetyl.
11. A compound as in anyone of claims 5 to 10 wherein Rj_ is hydrogen or lower alkyl.
12. A compound as in Claim 11 wherein R^ is hydrogen or methyl. -8844707
13. A compound as in Claim 5 wherein R is hydroxy and Rf is hydrogen or methyl.
14. A compound as in Claim 5 wherein R is hydroxy, is hydrogen or methyl, R^ i £ hydrogen or acetyl and n is 5 0, 1 or 2.
15. A compound as ift Claim 5 wherein R is hydroxy, Rf and R^ each is hydrogen and n is 0.
16. A compound as in Claim 5 wherein R is hydroxy, r, is hydrogen, R^ is acetyl and n is 1. 1θ
17. A compound as in Claim 5 wherein R is hydroxy, Rf is methyl, R^ is acetyl and n is 1.
18. A compound as in Claim 5 wherein R is hydroxy, Rf and R^ each is hydrogen and n is 1.
19. A compound as in Claim 5 wherein R is hydroxy, 15 R. is methyl, R is hydrogen and n is 1. x 2
20. A compound as in Claim 5 wherein R is hydroxy, Rf is hydrogen, R^ is benzoyl and n is 1.
21. The L-form of a compound of Claim 5.
22. The compound of Claim 19 in which the proline 10 is in the L-form.
23. A compound as in Claim 1 wherein R is hydroxy, Rf is hydrogen, R.. is lower alkylthio and n is 1.
24. A compound as in Claim 1 wherein is r-OC-J_N-OC-CH-CCHj) -S-; each R is hydroxy; each 25 Rf is hydrogen or lower alkyl; and each n is 0 to 2.
25. A compound as in Claim 24 wherein each R is hydroxy; each Rf is hydrogen and each n is 1.
26. The compound according to Claim 1 having.the name 1-(3-mercapto-2-D-methylpropanoyl)-L-proline. -8344707
27. The compound according to Claim 1 having the namel,1'-Cdithiobis(2-D-methyl-3-propanoy12 -his-L-proline.
28. The compound of Claim 1S in which the proline is in the L-forra. 5
29. The compound of Claim 17 in which the proline is in the L-form.
30. A pharmaceutical composition comprising a compound of any preceeding Claim and a pharmaceutically acceptable vehicle therefor. 10 51.
A pharmaceutical composition comprising a compound of Claim 19 and a pharmaceutically acceptable vehicle therefor.
32. A pharmaceutical composition comprising a compound of Claim 18 and a pharmaceutically acceptable vehicle therefor.
33. A pharmaceutical composition comprising the 15 compound of Claim 26 and a pharmaceutically acceptable vehicle therefor.
34. A pharmaceutical composition comprising the compound of Claim 27 and a pharmaceutically acceptable vehicle therefor. 20 35. A method for reducing blood pressure in non-human mammals which comprises administering a composition comprising a compound of any one of Claims 1 to 29 and a pharmaceutically acceptable vehicle therefor.
36. A method for reducing blood pressure in non-human 25 mammals which comprises administering a composition comprising a compound of Claim 19 and a pharmaceutically acceptable vehicle therefor. -904 4 7 0 7 • 37. A method for reducing blood pressure in non-humon mammals ahich comprises administering a composition comprising •a compound V 03 aim 18 sad a pharmaceutically acceptable vehicle. 5 33. A method for raducing blood pressure in non-human mammals which comprises administering a composition comprising a οοηρο.··ΐΐΐο·ι of Claim 26 zn4 a pharmaceutically acceptable vehicle the·.· if or.
33. A method for reducing blood pressure in non-human 10 mammals which comprises administering a composition comprizing the compound of Claim 27 and a pharmaceutically acceptable vehicle therefor. AO. A method for reducing blood pressure in non-huusii mammal s to any one c? claims 35 to 33, substantially as he ruin 15 duycri Ij.ri,
11. n compound of the lOrmiilo I 5 f Γ -1 H 2? ^ CI ^m -( CH)-CH-—CO-n-CII—OCR
2. Il wherein ti is hydroxy, amino or lower alkoxy; “1 and .-..j each is hydrogen, lower alkyl or phenyl· 20 lov ;er alkyl; is hydrogen or I^-CO; K 3 is hydrogen, hydroxy er lower alkyl; R 5 is loner alkyl, phenyl or phenyl-lower alkyl; a is 1,2,or 3; 25 n is 0, 1 or ?; or such a compound in the form of a salt with -a ba::i.·. -91.44707
42. A compound as in Claim 41, wherein a is hydroxy or lower alkoxy; R^ is hydrogen or lower alkyl; Rg is hydrogen or R^-CC; and R^ each is hydrogen; is lower alkyl or phenyl; m is 2 and n is 0, 1 or 2.
43. A compound as in Claim 41 wherein R-. and R. each • 2 4 is hydrogen.
44. A compound as in Claim 41 wherein n is 2 and R^ is hydrogen.
45. A pharmaceutical composition comprising a compound of Claim 41 and a pharmaceutically acceptable vehicle therefor.
46. A method for reducing blood pressure in nonhuman mammals by inhibiting the conversion of angiotensin I to angiotensin II which comprises administering a composition comprising a compound of Claim 41 and a pharmaceutically acceptable vehicle therefor.
47. A method for reducing blood pressure in nonhuman mammals by inhibiting the conversion of angiotensin I to angiotensin II which comprises administering a composition comprising a compound of Claim 42 and a pharmaceutically acceptable vehicle therefor.
48. A method of reducing blood pressure in non-human mammals by inhibiting the conversion of angiotensin I to angiotensin II which comprises administering a composition a compound of Claim 43 and a pharmaceutically acceptable vehicle therefor.
49. The compound of Claim I as named in any of the Examples.
50. A pharmaceutical composition comprising a compound of Claim,,49 and a pharmaceutically acceptable carrier therefor. 51.. The composition of Claim 30 in the form of a tablet, capsule, elixir or sterile injectable preparation. -92·
52. The conposition of Claim 30 or 51 which includes a binder, an excipient, a disintegrating agent, a lubricant, a sweetening agent, a flavouring agent, a preservative or a dye.
53. fl'v composition of Claim 45 in the form of a tablet, capsule, elixir cr sterile injectable preparation.
54. The composition of Claim 45 or 53 which include..: a binder, an excipient, a disintegrating agent, a lubricant, a sweetening agent, a flavouring agent, a prese= vutive or a aye.
55. The composition of Claim 50 in the form of a tablet, capsule, elixir or sterile injectable preparation.
56. The composition of Claim 50 or 55 which includes a binder, an excipient, a disintergrating agent, a lubricant, a sweetening agent, a flavouring agent, a preservative or a dye.
57. The composition of Claim 30 substantially as described in any of Examples 177-132.
53. a compound of the formula r (CH)„ -{ Ji!·/ g~~ ΟΗ-GO-II—Gil— -COK wherein Y is a protecting group and the other symbols are as defined in claim 1.
59. The compound of Claim 53 substantially as hereinbefore described.
60. Λ process for preparing a compound of the formuala H3R, r CC· i'2 c -fj3 -(CH) r -JOrt wherein the symbols are as defined in claim 1 which comprise, deprotecting a compound of the formula. - 93 R, I 4 -( CH) I 1 -CH-(CH) -CH-C0R vzherein Y is a protecting group.
61. A compound of the first formula given in Claim CO v/hen prepared by the process of Claim 60.
IE305/77A 1976-02-13 1977-02-11 Proline derivatives and related compounds IE44707B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US05/657,792 US4046889A (en) 1976-02-13 1976-02-13 Azetidine-2-carboxylic acid derivatives
US69843276A 1976-06-21 1976-06-21
US05/751,851 US4105776A (en) 1976-06-21 1976-12-22 Proline derivatives and related compounds

Publications (2)

Publication Number Publication Date
IE44707L IE44707L (en) 1977-08-13
IE44707B1 true IE44707B1 (en) 1982-03-10

Family

ID=27417986

Family Applications (1)

Application Number Title Priority Date Filing Date
IE305/77A IE44707B1 (en) 1976-02-13 1977-02-11 Proline derivatives and related compounds

Country Status (31)

Country Link
JP (1) JPS604815B2 (en)
AR (4) AR222445A1 (en)
AT (1) AT365569B (en)
AU (1) AU509899B2 (en)
BG (3) BG37075A3 (en)
CA (1) CA1101864A (en)
CH (3) CH622503A5 (en)
DD (1) DD129442B3 (en)
DE (2) DE2703828C2 (en)
DK (1) DK157487C (en)
ES (5) ES455803A1 (en)
FI (1) FI66596C (en)
FR (1) FR2340932A1 (en)
GB (1) GB1576161A (en)
GR (1) GR69811B (en)
HK (1) HK20281A (en)
HU (1) HU181965B (en)
IE (1) IE44707B1 (en)
IL (1) IL51297A (en)
IT (1) IT1062293B (en)
KE (1) KE3136A (en)
MY (2) MY8200075A (en)
NL (1) NL168509C (en)
NO (1) NO146985C (en)
NZ (1) NZ183130A (en)
PH (1) PH12970A (en)
PL (1) PL118161B1 (en)
RO (1) RO69941A (en)
SE (2) SE423812B (en)
SU (1) SU747422A3 (en)
YU (1) YU40664B (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206122A (en) * 1978-04-14 1980-06-03 E. R. Squibb & Sons, Inc. Derivatives of pyrrolidinecarboxaldehyde and piperidinecarboxaldehyde and intermediates therefor
US4053651A (en) 1976-05-10 1977-10-11 E. R. Squibb & Sons, Inc. Compounds and method for alleviating angiotensin related hypertension
AU518147B2 (en) * 1976-12-03 1981-09-17 E.R. Squibb & Sons, Inc. Derivatives of thiazolidine, thiazine and morpholine carboxylic acids
US4129566A (en) * 1978-02-15 1978-12-12 E. R. Squibb & Sons, Inc. Derivatives of dehydrocyclicimino acids
US4113715A (en) * 1977-01-17 1978-09-12 E. R. Squibb & Sons, Inc. Amino acid derivatives
FR2412537A1 (en) * 1977-12-22 1979-07-20 Science Union & Cie NEW SUBSTITUTE THIOBUTYRAMIDES, THEIR METHODS OF OBTAINING AND THEIR PHARMACEUTICAL APPLICATION
CA1120400A (en) * 1977-12-27 1982-03-23 Zola P. Horovitz Method of treating hypertension and medicaments therefor
PH15381A (en) * 1978-02-21 1982-12-17 Squibb & Sons Inc Halogen substituted mercaptoacylamino acids
JPS559058A (en) * 1978-07-06 1980-01-22 Dainippon Pharmaceut Co Ltd 1-(3-mercapto-2-methylpropanoyl)prolyl amino acid derivative
CA1109475A (en) * 1978-07-27 1981-09-22 Miguel A. Ondetti Thiopropanoylamino acid derivatives
CA1144930A (en) * 1978-08-11 1983-04-19 Miguel A. Ondetti Mercaptoacyl derivatives of substituted prolines
NZ190995A (en) * 1978-09-05 1982-03-09 American Cyanamid Co Substituted omega propionyl or butyryl l-prolines and pharmaceutical compositions
NL7809120A (en) * 1978-09-07 1980-03-11 Oce Andeno B V Grubbenvorsterw PROCESS FOR THE PREPARATION OF PROLINE DERIVATIVES.
NL7809121A (en) * 1978-09-07 1980-03-11 Oce Andeno B V Grubbenvorsterw OPTICALLY ACTIVE DERIVATIVES OF MERCAPTO-ISO BUTIC ACID.
GR73585B (en) * 1978-09-11 1984-03-26 Univ Miami
US4690937A (en) * 1979-08-14 1987-09-01 University Of Miami Anti-hypertensive agents
ZA794723B (en) * 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
JPS5540622A (en) * 1978-09-14 1980-03-22 Santen Pharmaceut Co Ltd Hypotensive agent
US4483861A (en) * 1978-10-31 1984-11-20 Santen Pharmaceutical Co., Ltd. Antihypertensive sulfur-containing compounds
US4198515A (en) * 1978-12-08 1980-04-15 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of 4,5-dihydro-1H-pyrrole-2-carboxylic acids and 1,4,5,6-tetrahydropyridine-2-carboxylic acids
US4410542A (en) 1978-12-30 1983-10-18 Santen Pharmaceutical Co., Ltd. Disulfide compounds
US4347371A (en) * 1978-12-30 1982-08-31 Santen Pharmaceutical Co., Ltd. Disulfide compounds
CA1138452A (en) * 1979-01-15 1982-12-28 John Krapcho Carbamate derivatives of mercaptoacyl hydroxy prolines
US4461896A (en) * 1979-02-07 1984-07-24 Norwich Eaton Pharmaceuticals, Inc. 1-[Acylthio) and (mercapto)-1-oxoalkyl]-1,2,3,4-tetrahydroquinoline-2-carboxylic acids
US4220791A (en) * 1979-03-08 1980-09-02 E. R. Squibb & Sons, Inc. Mercaptoacylpyrazolidinone carboxylic acid derivatives
ZA802420B (en) * 1979-05-18 1981-04-29 Squibb & Sons Inc Aminoacyl derivatives of mercaptoacyl amino acids
US4234489A (en) * 1979-06-25 1980-11-18 E. R. Squibb & Sons, Inc. Pyroglutamic acid derivatives and analogs
JPS5629403U (en) * 1979-08-13 1981-03-20
DE2937779A1 (en) * 1979-09-19 1981-04-09 Hoechst Ag, 6000 Frankfurt AMINO ACID DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
GB2066240A (en) * 1979-12-10 1981-07-08 Squibb & Sons Inc Derivatives of mercaptoacyl amino acids
GB2065643B (en) * 1979-12-13 1983-08-24 Kanegafuchi Chemical Ind Optically active n-mercaptoalkanoylamino acids
JPS5683483A (en) * 1979-12-13 1981-07-08 Santen Pharmaceut Co Ltd Thiazolidine compound
US4692458A (en) * 1980-03-05 1987-09-08 University Of Miami Anti-hypertensive agents
GB2070586A (en) * 1980-03-21 1981-09-09 Squibb & Sons Inc Derivatives of Proline or Pipecolic Acid
DE3011239A1 (en) * 1980-03-22 1981-10-01 C.H. Boehringer Sohn, 6507 Ingelheim SUBSTITUTED ALKYLTHIOACYLAMINO ACIDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS
SE8203245L (en) * 1981-05-27 1982-11-28 Crc Ricerca Chim PROCEDURE FOR ENANTIOSELECTIVE PREPARATION OF N-SUBSTITUTED PROLINE DERIVATIVES
KR860001391B1 (en) * 1984-07-23 1986-09-22 보령제약 주식회사 Process for the preparation of pyrolidines
JPH06740B2 (en) * 1984-08-16 1994-01-05 三菱レイヨン株式会社 Process for producing optically active carboxylic acid amide
HU196369B (en) * 1984-10-18 1988-11-28 Egyt Gyogyszervegyeszeti Gyar New process for producing n-acylized l-prolin derivatives
KR870001570B1 (en) * 1984-12-19 1987-09-04 보령제약 주식회사 Preparing process for pyrolidine derivatives
KR870001569B1 (en) * 1985-02-11 1987-09-04 보령제약 주식회사 Preparing process for pyrolidine derivatives
AT395012B (en) * 1986-06-27 1992-08-25 Richter Gedeon Vegyeszet METHOD FOR PRODUCING N- (1 (S) | THOXYCARBONYL-3-PHENYL-PROPYL) - (S) -ALANYL- (S) PROLIN AND ITS ACID ADDITION SALTS
JP2863534B2 (en) * 1988-10-24 1999-03-03 マリオン ラボラトリーズ，インコーポレイティド Pharmaceutical composition
US5026873A (en) * 1989-11-06 1991-06-25 E. R. Squibb & Sons, Inc. Process for direct isolation of captopril
DE59306051D1 (en) * 1992-08-26 1997-05-07 Beiersdorf Ag USE OF RADICAL CATCHERS AS IMMUNODULATING AGENTS IN COSMETIC AND DERMATOLOGICAL PREPARATIONS
DE4228455A1 (en) * 1992-08-26 1994-09-15 Beiersdorf Ag Cosmetic and dermatological sunscreen formulations containing thiols and / or thiol derivatives
IT1266570B1 (en) * 1993-07-30 1997-01-09 Zambon Spa DERIVATIVES OF PROPANAMIDE N-ETEROARYL SUBSTITUTES USEFUL IN THE TREATMENT OF CARDIOVASCULAR DISEASES
US7056935B2 (en) 1995-06-07 2006-06-06 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
GB9704522D0 (en) * 1997-03-05 1997-04-23 Smithkline Beecham Plc Compounds
ATE224366T1 (en) * 1997-10-31 2002-10-15 Hoffmann La Roche D-PROLINE DERIVATIVES
IL159983A0 (en) * 2001-08-07 2004-06-20 Sunesis Pharmaceuticals Inc Disulfide and thiosulfonate ligands and libraries comprising these ligands
CN100361971C (en) * 2005-09-19 2008-01-16 华中师范大学 Double functional group L-proline derivative with adjustable catalytic activity and its prepn
US8653131B2 (en) 2008-08-22 2014-02-18 Baxter Healthcare S.A. Polymeric benzyl carbonate-derivatives
RU2623233C2 (en) 2012-04-27 2017-06-23 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Pesticidal compositions and methods related thereto

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA946836A (en) * 1970-03-18 1974-05-07 Miguel A. Ondetti Enzyme inhibitor

Also Published As

Publication number Publication date
DE2759862C2 (en) 1989-12-07
NZ183130A (en) 1979-08-31
NO146985C (en) 1983-01-12
AR222783A1 (en) 1981-06-30
HK20281A (en) 1981-05-22
GB1576161A (en) 1980-10-01
DK157487B (en) 1990-01-15
YU40664B (en) 1986-04-30
PL195965A1 (en) 1978-02-27
YU33177A (en) 1983-01-21
IT1062293B (en) 1984-05-23
PH12970A (en) 1979-10-24
ES467053A1 (en) 1978-11-01
FI66596C (en) 1987-03-18
DE2703828A1 (en) 1977-08-18
DE2703828C2 (en) 1984-06-20
ES467052A1 (en) 1978-11-01
CH624932A5 (en) 1981-08-31
ATA98977A (en) 1981-06-15
SE423812B (en) 1982-06-07
SE426697B (en) 1983-02-07
JPS604815B2 (en) 1985-02-06
DK59677A (en) 1977-08-14
AU509899B2 (en) 1980-05-29
SE7701561L (en) 1977-09-23
BG37074A3 (en) 1985-03-15
FR2340932A1 (en) 1977-09-09
CA1101864A (en) 1981-05-26
JPS52116457A (en) 1977-09-29
IL51297A0 (en) 1977-03-31
BG37375A3 (en) 1985-05-15
CH624931A5 (en) 1981-08-31
NO770464L (en) 1977-08-16
SE8104660L (en) 1981-08-03
IL51297A (en) 1980-03-31
AR214649A1 (en) 1979-07-13
FI770437A (en) 1977-08-14
NO146985B (en) 1982-10-04
NL168509C (en) 1982-04-16
FR2340932B1 (en) 1981-02-06
DK157487C (en) 1990-06-11
ES467051A1 (en) 1978-11-01
PL118161B1 (en) 1981-09-30
AU2134777A (en) 1978-07-20
RO69941A (en) 1980-05-15
AT365569B (en) 1982-01-25
NL7701457A (en) 1977-08-16
SU747422A3 (en) 1980-07-23
AR222445A1 (en) 1981-05-29
CH622503A5 (en) 1981-04-15
DD129442A5 (en) 1978-01-18
BG37075A3 (en) 1985-03-15
IE44707L (en) 1977-08-13
AR226290A1 (en) 1982-06-30
KE3136A (en) 1981-07-03
GR69811B (en) 1982-07-13
ES455803A1 (en) 1978-06-16
HU181965B (en) 1983-11-28
MY102705A (en) 1992-09-30
FI66596B (en) 1984-07-31
MY8200075A (en) 1982-12-31
DD129442B3 (en) 1990-01-10
ES467050A1 (en) 1978-11-01

Similar Documents

Publication Publication Date Title
IE44707B1 (en) Proline derivatives and related compounds
US4105776A (en) Proline derivatives and related compounds
US4154840A (en) Antihypertensive pipecolic acid derivatives
CA1144930A (en) Mercaptoacyl derivatives of substituted prolines
US4316906A (en) Mercaptoacyl derivatives of substituted prolines
CA1124725A (en) Alkanoyl-thio-acyl derivatives of dehydrocyclicimino acids
US4128653A (en) Reduction of blood pressure with carboxyalkylacyl-pipecolic acid derivatives
US4296113A (en) Mercaptoacyl derivatives of keto substituted proline and pipecolic acid
CH634830A5 (en) METHOD FOR PRODUCING NEW SUBSTITUTED AMINO ACIDS.
US4154937A (en) Hydroxycarbamoylalkylacylpipecolic acid compounds
US4241076A (en) Halogenated substituted mercaptoacylamino acids
CA1124723A (en) Halogen substituted mercaptoacylamino-prolines and pipecolic acids
CA1103257A (en) Proline derivatives and related compounds
CA1103256A (en) Proline derivatives and related compounds
US4181663A (en) Selenium containing derivatives of proline and pipecolic acid
CA1102337A (en) Proline derivatives and related compounds
CA1103255A (en) Proline derivatives and related compounds
KR810000056B1 (en) Process for preparing proline derivatives and related compounds
US4330548A (en) Mercaptoacyl derivatives of keto substituted pipecolic acid
CA1138878A (en) Mercaptoacyl derivatives of keto substituted proline and pipecolic acid
GB2070586A (en) Derivatives of Proline or Pipecolic Acid
NL8104046A (en) Hypotensive mercaptoacyl-proline derivs. - prepd. by acylating proline or its analogues with mercapto-carboxylic acid derivs. (BE 11.8.77)

Legal Events

Date Code Title Description
QU9A Proceedings under sections 42 and 44 of the patent act 1964 (application for a licence)
MK9A Patent expired